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Abstract

Biological Mechanisms Linking Stress and Anhedonia

Colin Ho-Ming Stanton
2021

Evidence from research across species suggests that stress exposure is linked with
anhedonia (loss of pleasure and/or decreased motivation). However, the mechanisms
through which stress might impact anhedonia remain unclear. Chapters 1 and 2 of this
dissertation review putative etiological pathways from stress to anhedonia and discuss
stressor characteristics that could inform experimental models of stress-induced
anhedonia. Chapter 3 describes an attempt to identify which types of stress are most
associated with anhedonia using stress interview data from multiple datasets.
Unexpectedly, we found no credible effects on anhedonic symptoms for stressor
chronicity, severity, dependence on behavior, or interpersonal focus. Instead, number of
stressors endorsed was the best predictor of anhedonic symptoms. Next, Chapters 4 and 5
report on two studies that tested possible biological mediators of the stress-anhedonia
link. Chapter 4 describes an analysis of the UK Biobank dataset aimed at evaluating
frontostriatal functional connectivity as a mechanism of stress-induced anhedonia.
Although stress exposure predicted anhedonia, analyses uncovered no stable relation
between frontostriatal connectivity and anhedonia, and no support for the proposed
mediation model. Chapter 5 details a study that implemented a laboratory-based stressor
to assess its potential impact on motivated behavior (thought to be a key component of
anhedonia), and whether any such effects might be mediated by inflammatory
i

responding. Low concentrations of salivary cytokines suggested questionable validity of
inflammatory assessment, and no effect of stress on inflammatory responding was
observed. Additionally, stress produced no measurable changes in motivated behavior.
Thus, analyses revealed no evidence consistent with inflammation as a mechanism of
stress-induced anhedonia. Finally, Chapter 6 discusses conclusions and implications of
the current findings, and provides ideas for future directions.
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Chapter 1: General Introduction

1

General Introduction
Anhedonia, defined as the loss of pleasure and/or motivation to engage in valued
activities, is a debilitating condition observed in several psychiatric disorders, including
major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and
schizophrenia (Barch & Dowd, 2010; Nawijn et al., 2015; Pizzagalli, 2014). Anhedonia
has been linked to suicide completion among individuals with MDD (Fawcett et al.,
1990) and is poorly treated by serotonergic antidepressants (Nutt et al., 2007).
Additionally, disorders characterized by anhedonia exert a significant personal, societal,
and economic toll worldwide (Whiteford et al., 2013). Reducing the burden of anhedonia
could therefore lead to substantial benefit. However, the causal pathways to anhedonia
remain poorly understood, limiting innovation in diagnosis, treatment, and prevention.
Focusing on the etiology of anhedonia, as opposed to a broader psychiatric
phenotype such as MDD, may yield more reliable findings than applying widely-used
diagnostic categories. Indeed, considerable heterogeneity in the presentation of these
diagnostic categories likely hampers investigation into possible causal mechanisms, since
current diagnoses accommodate a wide variety of symptom presentations with potentially
disparate etiologies (Fried, 2017). For example, one study identified over 1,000 unique
symptom profiles for individuals with MDD, some of which did not share a single
common symptom (Fried & Nesse, 2015). Furthermore, these diagnostic categories are
inherently descriptive in nature, and were derived from clinical observation rather than
knowledge of causal mechanisms (Clark, Cuthbert, Lewis-Fernández, Narrow, & Reed,
2017). By contrast, delineating the mechanistic pathways that contribute to specific
symptoms could produce more constrained, empirically-defined phenotypes.
2

One possible approach to identifying an etiological pathway to anhedonia is to
begin with a precipitating factor, such as exposure to psychological stressors. Crossspecies work suggests that stress exposure contributes to anhedonic-like (i.e., diminished
reward-seeking) behavior in nonhuman animals (Anisman & Matheson, 2005; Hollon,
Burgeno, & Phillips, 2015; Russo & Nestler, 2013) and decreased behavioral sensitivity
to rewards as well as increased self-reported anhedonic symptoms in humans (Pizzagalli,
2014). (For more on the link between stress and anhedonia, see the literature review in
Chapter 2.) Yet much remains unknown about the connection between stress and
anhedonia.
For instance, little is known about the dimensions of stress that most strongly
predict anhedonia. Nonhuman animal studies of stress-induced anhedonia vary in the
chronicity, severity, and type of stress implemented (Anisman & Matheson, 2005).
However, few studies in humans have addressed the effects of different types of stressors
on anhedonia, and as a result the validity of these preclinical models remains unclear.
Human subjects research by Keller, Neale, and Kendler (2007) using a large sample of
twins suggests that anhedonia may be especially common following some types of
stressors (e.g., death of a loved one or romantic loss) relative to others. Yet while this
design tested the relative impact of different categories of stress on patterns of depressive
symptoms, the roles of potentially important factors, such stress severity, were not
assessed. Additionally, chronic stressors were grouped into a single category, while acute
stressors were categorized according to the theme of the stressor (e.g., “personal failure
or abandoned goals”), making it difficult to compare acute and chronic stressors directly.
Thus, follow-up work is needed to investigate the impact of key dimensions of stress,
3

including severity and chronicity, on anhedonia. A more fine-grained understanding of
how certain stressors are differentially associated with anhedonia could inform the
implementation of ecologically-valid stress manipulations across species. This
knowledge could also help identify which individuals are at risk for developing
anhedonia, which could inform further research (e.g., using longitudinal high-risk
designs) and preventative care.
Furthermore, the mechanisms through which stress may influence risk for
anhedonia remain largely unknown. However, some evidence suggests that alterations in
medial prefrontal cortex (mPFC) interactions with mesolimbic circuitry, including ventral
tegmental area (VTA) and nucleus accumbens (NAc), could contribute to decreases in
motivated behavior following stress (Russo & Nestler, 2013). As for how stress might
perturb these frontostriatal dynamics, several hypotheses have been put forward. Some
studies suggest that stress exposure could increase anhedonia risk by producing mPFC
hypofunction (Covington et al., 2010; Ossewaarde et al., 2011; Treadway, Buckholtz, &
Zald, 2013), whereas other findings suggest increased mPFC excitability could account
for decreases in motivated behavior (Ferenczi et al., 2016; Moreines, Owrutsky, & Grace,
2017). These seemingly contradictory findings are further explored in Chapter 2.
Nevertheless, evidence suggests that frontostriatal interactions are a worthy target for
future study as a possible mechanism of stress-induced anhedonia. Many of the key
studies described here were conducted in rodents (Chaudhury et al., 2012; Covington et
al., 2010; Ferenczi et al., 2016; Moreines et al., 2017). Additionally, human studies have
typically not tested whether frontostriatal connectivity statistically mediates the relation
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between stress and anhedonia (Ossewaarde et al., 2011; Treadway et al., 2013). Thus, this
model awaits further testing in a sufficiently large human-subjects sample.
In addition to frontostriatal functioning, inflammatory responses might play a role
in stress-induced anhedonia, possibly by impacting dopaminergic reward responses
(Felger & Treadway, 2017). This hypothesis and relevant findings are discussed in
greater detail in Chapter 2. Briefly, in rhesus monkeys, chronic administration of
interferon-α, a pro-inflammatory cytokine, decreased effort-based sucrose consumption
and blunted dopamine release in the caudate following stimulation (Felger, Mun, et al.,
2013). Follow-up investigation revealed that these deficits were abolished by
administration of L-DOPA, the precursor to dopamine (Felger, Hernandez, & Miller,
2015). Together, these findings suggest that inflammation could produce anhedonia by
disrupting dopamine synthesis. Additionally, following social defeat stress in rodents, the
inflammatory cytokine interleukin-6 (IL-6) increases in blood circulation and appears to
infiltrate nucleus accumbens. In conjunction with synaptic remodeling in NAc after stress
(J. Wang et al., 2018), IL-6 infiltration across the blood-brain barrier may contribute to
the development of anhedonic-like behavior in rodents (Hodes et al., 2014; Menard et al.,
2017; J. Wang et al., 2018).
However, in human studies, evidence is considerably more mixed. In one fMRI
study, stress-induced increases in IL-6 were associated with diminished reward prediction
error-linked responses in ventral striatum following stress, but no behavioral effects
emerged (Treadway et al., 2017). Additionally, a recent study found that stress-induced
increases in IL-6 mediated the impact of stress on changes in reward responsiveness
(Boyle, Stanton, Eisenberger, Seeman, & Bower, 2020). However, unexpectedly, stress5

induced IL-6 was associated with increased reward responsiveness (Boyle et al., 2020).
Given promising findings in nonhuman animal models, more work is needed to clarify
the connections between stress, inflammation, and subsequent reward processing.
In summary, research suggests that stress contributes to the onset of anhedonia.
However, the impact of key dimensions of stress on anhedonia remains unclear,
potentially limiting the ecological validity of preclinical models and hindering the search
for plausible mediators. Additionally, few studies have assessed promising mechanisms
of stress-induced anhedonia (e.g., frontostriatal connectivity, inflammatory responses) in
humans. Addressing these empirical gaps could aid the elaboration of etiological
pathways to anhedonia. The delineation of such pathways is essential to the creation of a
more constrained, empirically-derived phenotype, which could facilitate diagnosis and
provide targets for novel clinical interventions.
Overview of Dissertation Chapters
The broad goal of this dissertation is to better characterize the link between stress
and anhedonia. Chapter 2 provides a literature review that covers putative biological
mechanisms of stress-induced anhedonia and provides additional relevant background
information. Chapter 3 presents an attempt to statistically model the impact of key
dimensions of stress (including chronicity and severity) on anhedonia. Chapter 4
describes an investigation of mPFC functional connectivity with NAc, a key node of the
mesolimbic reward circuit, to determine whether frontostriatal dynamics could plausibly
mediate the effect of stress on anhedonia. Next, Chapter 5 details an examination of
inflammatory responses to a laboratory stressor and their association with subsequent
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motivated behavior. Finally, a synthesis of results and ideas for future directions are
presented in Chapter 6.
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Chapter 2: Literature Review
From Stress to Anhedonia: Molecular Processes through
Functional Circuits

Adapted from:
Stanton, C. H., Holmes, A. J., Chang, S. W. C., & Joormann, J. (2019).
From stress to anhedonia: Molecular processes through functional circuits.
Trends in Neurosciences, 42(1), 23–42.

© 2018 Elsevier Ltd., reprinted with permission
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Abstract
Converging evidence across species highlights the contribution of environmental
stress to anhedonia (loss of pleasure and/or motivation). However, despite a clear link
between stress and the emergence of anhedonic-like behavior in both human and animal
models, the underlying biological pathways remain elusive. Here, we synthesize recent
findings across multiple levels, from molecular signaling pathways through whole-brain
networks, to discuss mechanisms through which stress may influence anhedonia. Recent
work suggests the involvement of diverse systems that converge on the mesolimbic
reward pathway, including medial-prefrontal cortical circuitry, neuroendocrine stress
responses, homeostatic energy regulation systems, and inflammation. We conclude by
emphasizing the need to disentangle the influences of key dimensions of stress on
specific aspects of reward processing, taking into account individual differences that
could moderate this relationship.

9

Introduction
Our response to environmental stressors helps to guide decision-making in an
evolutionary balancing act that pits the pursuit of rewards, crucial for survival and
reproduction (e.g., food and mating opportunities), against potential threats (e.g.,
predators and pathogens) (A. J. Holmes & Patrick, 2018; Lima, 1998). Stressors can tip
this balance by decreasing reward-seeking behavior (Anisman & Matheson, 2005). Seen
through an evolutionary lens, decreased approach behavior in response to environmental
threats may be highly adaptive in some contexts. For example, following physical harm
or the threat of infectious disease, anhedonia (see Glossary) and social withdrawal may
preserve resources for healing wounds and inhibit the spread of pathogens (A. H. Miller
& Raison, 2016; Raison & Miller, 2016). However, the adaptive value of a given trait or
behavior is sensitive to both environmental context and complex interactions across
cognition, behavior, and genetics (Dingemanse, Kazem, Réale, & Wright, 2010; A. J.
Holmes & Patrick, 2018). For some individuals with existing vulnerabilities, such as
ruminative coping styles following a traumatic event (Michael, Halligan, Clark, & Ehlers,
2007), stress responses culminating in anhedonia can trigger the onset of psychiatric
illness.
In this review we highlight some of the diverse circuit-level and molecular
mechanisms through which stress could lead to anhedonia. In doing so, we adopt a multisystem, multi-level approach, in which we examine how the effects of stress may echo
across levels of analysis (e.g., molecular processes and functional circuits) and involve
interactions between diverse systems (e.g., immune responses that alter brain reward
functioning). We first discuss likely contributors to stress-induced anhedonia at the level
10

of neurocircuitry, including systems that govern motivated behavior, neuroendocrine
responses to stress, and energy homeostasis. Next, we review possible pathways to
stress-induced anhedonia at the molecular level, with a particular focus on immune
system signaling pathways. We conclude with a roadmap of promising future directions
in the study of stress and anhedonia.
Impact of Stress on Anhedonia
Research across species, including rodents and humans, has demonstrated a link
between stress and anhedonic-like behaviors (Anisman & Matheson, 2005; Hollon et al.,
2015; Pizzagalli, 2014; Russo & Nestler, 2013). Here, we briefly review evidence of this
relationship. Readers should note that more detailed reviews covering cross-species work
on stress and anhedonia are available elsewhere (Anisman & Matheson, 2005; Hollon et
al., 2015; Pizzagalli, 2014; Russo & Nestler, 2013).
Rodent studies have employed a variety of stress manipulations. These include
social defeat stress, in which a rodent is placed in proximity to another, aggressive rodent
and subjected to physical attack (Golden, Covington, Berton, & Russo, 2011); and
chronic mild stress (CMS), in which rodents are exposed to an unpredictable series of
stressors, including 24-hour light cycle, food deprivation, and damp bedding (Tye et al.,
2013; Willner, 2005). Research groups employing these approaches have discovered
associated decreases in reward-seeking behaviors, suggestive of decreased pleasure
and/or motivation. Social defeat and CMS in rodents, for example, produce blunted
sucrose preference and/or diminished social interaction (Hollon et al., 2015; Russo &
Nestler, 2013; Willner, 2005).
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Although considerably less work has focused on the study of stress and anhedonia
in humans, results are broadly consistent with the nonhuman animal literature (Ironside,
Kumar, Kang, & Pizzagalli, 2018; Pizzagalli, 2014). Following naturally-occurring
stressors (e.g., medical residence examinations; Soares et al., 2012), individuals selfreport decreased pleasure in daily activities (Berenbaum & Connelly, 1993) and exhibit
lowered sensitivity to reward devaluation (Soares et al., 2012). Laboratory studies using
threat of shock as a stressor (Berghorst, Bogdan, Frank, & Pizzagalli, 2013; Bogdan &
Pizzagalli, 2006) have found decreased response bias toward rewarded outcomes
(Bogdan & Pizzagalli, 2006) and diminished reward sensitivity (Berghorst et al., 2013).
In support of this experimental evidence, large, observational studies have established a
link between life stress and phenotypes that are often marked by anhedonia, such as
major depressive disorder (MDD) (Brown & Harris, 1978; Hammen, 2005; Kendler,
Karkowski, & Prescott, 1999). Notably, few large-scale studies have assessed the impact
of stress on anhedonia per se (for an exception, see Keller et al., 2007), and therefore
more work is needed to examine individual symptoms. In all, converging evidence across
species suggests that stress can produce anhedonic behavior.
Putative Circuit-level Mediators of Stress-Induced Anhedonia
Effects of stress on motivated behavior depend on the interplay of systems
spanning medial prefrontal cortex (mPFC), midbrain and striatum, amygdala,
hypothalamus, brainstem, and other regions implicated in reward processing (Russo &
Nestler, 2013) (Box 1). Due to space constraints, we focus on the contributions of three
brain systems: mesocorticostriatal reward circuits (mPFC, midbrain, and striatum);
subcortical stress response circuits (including hypothalamus and extended amygdala);
12

and brainstem-based energy homeostasis circuits (including GLP-1 neurons). Readers
should note that although we discuss these separately for the purposes of organization,
the distinctions are largely arbitrary. The amygdala, for instance, is involved in reward
processing (Murray, 2007). Other reviews cover emerging research on the contributions
of mu opioid systems (Ironside et al., 2018) and the lateral habenula (Yang, Wang, Hu, &
Hu, 2018), and provide a more molecular-level focus on stress-induced changes in
corticostriatal circuitry (Russo & Nestler, 2013).

Figure 1. Putative circuit-level and molecular mechanisms of stress-induced anhedonia.
(A) Social defeat stress (10 days) increased the firing rate of VTA dopamine neurons, but
only in the “susceptible” group (those animals that developed anhedonic-like behaviors
following stress) (Cao et al., 2010; Friedman et al., 2014; Krishnan et al., 2007). Chronic
mild stress (4-7 weeks) decreased the number of spontaneously active VTA dopamine
13

neurons (Chang & Grace, 2014; Moreines et al., 2017; Tye et al., 2013). (B) Some work
suggests that increased mPFC excitability could suppress activity in the mesolimbic
pathway (Ferenczi et al., 2016; Moreines et al., 2017). (C) Endogenous CRF release in
VTA seems to mediate the effect of restraint stress on motivation to work for food
reward, likely by decreasing phasic dopamine responses to reward (Wanat, Bonci, &
Phillips, 2013). (D) GLP-1 signaling appears to mediate the hypophagic effects of
restraint stress (Maniscalco, Zheng, Gordon, & Rinaman, 2015), likely by decreasing the
rewarding value of food (S. L. Dickson et al., 2012). GLP-1 neurons in cNST project
directly to VTA and NAc (Alhadeff, Rupprecht, & Hayes, 2012), where they appear to
influence dopaminergic functioning, although the direction of the effect is unclear (Fortin
& Roitman, 2017; Mietlicki-Baase et al., 2014, 2013; X. F. Wang et al., 2015). More
research is needed to assess whether GLP-1 neurons (and other homeostatic energy
systems) contribute to stress-induced anhedonia. (E) Inflammation may inhibit dopamine
availability (Felger, Hernandez, et al., 2015), either by inhibiting the function of enzymes
in the dopamine biosynthetic pathway (see (Felger & Treadway, 2017)) or by creating
oxidative stress through increased kynurenine (Dantzer, 2016). BST, bed nucleus of the
stria terminalis; CeA, central nucleus of the amygdala; cNST, caudate nucleus of the
solitary tract; CRF, corticotropin-releasing factor; DA, dopamine; GABA, γAminobutyric acid; GLP-1, glucagon-like peptide-1; IEG, immediate-early gene; mPFC,
medial prefrontal cortex; MSN, medium spiny neuron; NAc, nucleus accumbens; PVN,
hypothalamic paraventricular nucleus; VTA, ventral tegmental area.

Stress and the mesolimbic reward circuit.
The mesolimbic reward circuit, which includes the ventral tegmental area (VTA)
and nucleus accumbens (NAc), plays a key role in reward processing and motivated
behavior (Box 1). A substantial literature has addressed whether the functioning of this
circuit, in particular dopaminergic signaling, may mediate the effects of stress on
subsequent anhedonic-like behavior (Cabib & Puglisi-Allegra, 2012; Hollon et al., 2015;
Russo & Nestler, 2013).
Seemingly conflicting reports have emerged regarding VTA spontaneous
dopaminergic firing and anhedonic-like responses to stress (Hollon et al., 2015). Several
studies using social defeat stress have reported increased firing rates in “susceptible”
mice—that is, those which exhibited decreased social interactions and decreased sucrose
14

preference (Cao et al., 2010; Friedman et al., 2014; Krishnan et al., 2007). Yet other
studies in rats found that CMS decreased the number of spontaneously firing neurons,
leading to decreased mobility in the forced swim test, which is thought to represent
anhedonic-like behavior (Chang & Grace, 2014; Moreines et al., 2017). These studies
generally found no significant change in firing rates (except Chang & Grace, 2014,
Experiment 3). One possibility is that stress may induce increased firing rates in VTA
dopamine neurons, but a decreased number of spontaneously active neurons.
Experimental manipulations of dopaminergic firing have also exerted apparently
divergent effects on anhedonic behavior (Chaudhury et al., 2012; Tye et al., 2013). For
example, induced phasic dopaminergic firing (via optogenetics) in VTA rescued
decreases in sucrose preference caused by CMS (Tye et al., 2013). Yet a study of social
defeat stress found that optogenetically-induced phasic dopaminergic firing rendered
mice more susceptible to anhedonic effects of stress, as reflected in reduced sucrose
preference and decreased social interaction (Chaudhury et al., 2012).
Numerous differences in study design could account for these apparently
discrepant findings. As others have noted (Hollon et al., 2015), several parameters varied
across studies, including stressor type (social defeat vs. chronic mild stress), chronicity
(10 days of social defeat vs. 4-6 weeks of CMS), and measure of dopaminergic activity
(number of spontaneously active neurons vs. neuronal firing rate). It is possible that stress
could decrease the number of spontaneously active dopamine neurons (Chang & Grace,
2014; Moreines et al., 2017) while also increasing firing rates of the remaining,
spontaneously active dopamine neurons (Cao et al., 2010; Friedman et al., 2014;
Krishnan et al., 2007) in susceptible animals. However, few studies report both measures.
15

Also, studies of CMS often report main effects of stress, but rarely distinguish between
susceptible and unsusceptible rodents.
Additionally, VTA contains phenotypically diverse dopamine neurons. Some
VTA dopamine neurons co-release glutamate or GABA (Morales & Margolis, 2017), and
VTA dopamine neurons follow diverse projection pathways (Ikemoto, 2007; Morales &
Margolis, 2017). Thus, responses to stress may depend on the population of VTA neurons
under study. For example, CMS produces a decrease in spontaneously active dopamine
neurons in medial VTA (which primarily project to NAc) and central VTA, but not
lateral VTA (Moreines et al., 2017); and susceptibility to social defeat increases after
phasic stimulation of VTA projections to NAc, but not projections to mPFC (Chaudhury
et al., 2012).
Taken together, existing literature suggests that stress impacts dopaminergic
functioning, but the underlying mechanisms remain unclear. Further work may clarify
which qualities of stressors affect dopaminergic firing rates vs. number of spontaneously
active neurons, and whether such changes are necessary and sufficient to produce
anhedonic behavior following stress.
Medial prefrontal cortex regulation of the mesolimbic circuit.
What is the mechanism through which stress impacts mesolimbic dopamine
activity and perturbs reward functioning? Stress causes wide-ranging changes in brain
structure and function, including in hippocampus, amygdala, and across PFC (Arnsten,
2009; McEwen et al., 2015). These interconnected regions may therefore mediate the
effects of stress on anhedonia, especially given their roles in fear conditioning and
responding (LeDoux, 2000; Milad & Quirk, 2002; Phelps, Delgado, Nearing, & LeDoux,
16

2004) and guiding behavior based on incentive value (Kable & Glimcher, 2007; Murray,
2007; Rangel & Hare, 2010). To highlight exciting recent work spanning rodents
(Ferenczi et al., 2016; Moreines et al., 2017) and humans (Admon & Pizzagalli, 2015;
Drysdale et al., 2017), this section focuses on the mPFC-mesolimbic circuit.
Stress may perturb mPFC-mesolimbic interactions via structural changes, such as
dendritic remodeling, in mPFC (McEwen & Morrison, 2013). Specifically, in rats,
chronic restraint stress or chronic immobilization cause dendritic shrinkage and spine loss
in mPFC (prelimbic and infralimbic cortex) (McEwen & Morrison, 2013). In humans,
stress increases risk for several psychiatric disorders that commonly involve anhedonic
symptoms: MDD, schizophrenia, and post-traumatic stress disorder (PTSD) (Barch &
Dowd, 2010; Nawijn et al., 2015; Pizzagalli, 2014). These disorders are also marked by
decreased mPFC gray matter volume (MDD and PTSD) (Bremner, 2002; A. J. Holmes et
al., 2012; Schmaal et al., 2017) or accelerated gray matter loss in mPFC (schizophrenia)
(Cannon et al., 2015). These gray matter differences are relatively subtle in nature
(Cannon et al., 2015; A. J. Holmes & Patrick, 2018; Schmaal et al., 2017). For instance,
an estimated <1% annual change in cortical thickness characterizes converters to
schizophrenia, although effect sizes for the comparison with high-risk non-converters and
controls ranged from medium to large (Cannon et al., 2015). Additionally, mPFC volume
may also relate to illness chronicity: As one example, left mPFC cortical thickness in
patient populations is inversely related to number of depressive episodes (Treadway et
al., 2015). Further work is needed to elucidate the mechanism through which these
structural changes might give rise to alterations in mPFC function.
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Given these stress-induced changes in mPFC structure, researchers have tested the
hypothesis that stress produces anhedonia through mPFC hypofunction. In mice
exhibiting anhedonic-like behavior (decreased sucrose preference and decreased social
interaction) following social defeat stress, optogenetically-induced phasic firing in mPFC
(prelimbic and infralimbic) attenuated these deficits (Covington et al., 2010). This result
could suggest that induced phasic firing compensated for a deficit in mPFC activity. In
one study, following social defeat stress, the firing rate of VTA dopamine neurons
projecting to mPFC decreased by about 80% (Chaudhury et al., 2012), suggesting that
decreased dopaminergic input to mPFC may directly contribute to mPFC hypoactivity.
Work in humans also supports the mPFC hypofunction hypothesis: Perceived life stress
(Treadway et al., 2013) and stress induced by aversive video clips (Ossewaarde et al.,
2011) are associated with decreased blood oxygenation level dependent (BOLD) activity
in mPFC during reward anticipation and receipt. By itself, this evidence is consistent with
the notion that stress leads to mPFC hypofunction and related decreases in motivated
behavior.
Yet other findings suggest a more complex relation between mPFC-striatal
activity and motivated behavior. In a key study, researchers employed optogenetic
techniques in rats to stably increase excitability of mPFC (primarily infralimbic) neurons
(Ferenczi et al., 2016). Increased mPFC excitability led to reversible reductions in reward
seeking, as evidenced by decreased sucrose preference and social interaction.
Furthermore, increased mPFC excitability led to blunted BOLD responses in dorsal
striatum following dopaminergic midbrain excitation. This result suggests that
heightening mPFC excitability caused decreased reward-seeking behavior by altering
18

interactions between midbrain dopamine neurons and the striatum (Ferenczi et al., 2016)
through an unknown mechanism. This interpretation was supported by a recent study
examining CMS and dopaminergic functioning in rats (Moreines et al., 2017). In nonstressed rats, pharmacological activation of mPFC (infralimbic) selectively inhibited
dopamine neurons in medial VTA. CMS decreased the number of spontaneously firing
dopamine neurons in medial and central, but not lateral, VTA. This decrease was rescued
by pharmacological inactivation of mPFC (infralimbic) (Moreines et al., 2017). However,
following a social defeat paradigm, the synaptic strength of mPFC-to-ventral striatal
connections did not significantly differ between stress-susceptible and resilient mice
(Christoffel et al., 2015), suggesting no contribution of this pathway to subsequent
anhedonic behavior. This seemingly discrepant finding could be explained by indirect,
rather than direct, influences of mPFC function on mesolimbic activation (Moreines et
al., 2017). Alternately, different types of stress—e.g., CMS vs. social defeat stress—may
exert different impacts on corticostriatal pathways (see Future directions in the study of
stress and anhedonia). Nevertheless, when taken together, these results provide
evidence that mPFC hyperactivity may contribute to anhedonia following stress.
Recent work in humans also suggests that mPFC-striatal connectivity may
contribute to anhedonia in individuals with MDD and remitted MDD (rMDD). One study
examined individuals with rMDD using spectral dynamic causal modeling of BOLD
functional connectivity (Admon & Pizzagalli, 2015), an analytic approach that uses
Bayesian inference to estimate directional interactions between neural systems. In
response to a naturalistic positive mood induction, individuals with rMDD exhibited less
reciprocal mPFC-ventral striatal connectivity and were characterized instead by mPFC
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modulation of ventral striatum (VS), relative to controls (see Box 1 for a discussion of
corticostriatal structure and function). This pattern of functional connectivity in
individuals with rMDD was accompanied by lower mood approximately 30 minutes
following the induction (Admon & Pizzagalli, 2015).
A second study endeavored to characterize biological sub-phenotypes
(“biotypes”) in large samples of individuals with MDD using BOLD functional
connectivity data and MDD symptoms (Drysdale et al., 2017). Hierarchical clustering
analyses yielded four biotypes based on similar patterns of connectivity features.
Hyperconnectivity in frontostriatal (and thalamic) networks characterized two of the
biotypes, and this hyperconnectivity was associated with anhedonia and psychomotor
retardation (Drysdale et al., 2017). These results are consistent with the hypothesis that
mPFC interaction with mesolimbic circuitry regulates motivation.
In summary, evidence suggests that a) stress causes dendritic shrinkage and spine
loss in mPFC; b) mPFC activity alters mesolimbic dynamics; and c) mPFC may mediate
the impact of stress on mesolimbic function and anhedonia. Notably, to fully capture the
role of mPFC in stress-induced anhedonia, it may be necessary to examine how various
subregions of mPFC coordinate with other brain regions implicated in stress.
Neuroendocrine stress responses and mesolimbic reward processing.
Neuroendocrine stress responses induce a variety of physiological changes to
cope with threat, such as mobilizing stored energy for use by muscle (Sapolsky, Romero,
& Munck, 2000). In addition, neuroendocrine responses may inhibit or enhance reward
seeking, depending on site of action and prior stress exposure (see below). Thus,
neuroendocrine activity is also poised to mediate the link between stress and anhedonia.
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Much of the research on this possibility has focused on corticotropin-releasing factor
(CRF), a key component of HPA axis functioning (see Box 2 and Figure 2).

Figure 2. Neuroendocrine and inflammatory stress responses. The PVN releases CRF,
which reaches the pituitary gland through the median eminence. CRF binding in the
pituitary gland causes ACTH release into circulation (Smith & Vale, 2006). Circulating
ACTH reaches binding sites in the adrenal cortex, releasing glucocorticoids (in humans,
primarily cortisol) (Smith & Vale, 2006). Glucocorticoids act on immune cell receptors to
downregulate pro-inflammatory cytokines, decreasing inflammation. At the same time,
SNS terminals at release catecholamines at peripheral sites (Elenkov, Wilder, Chrousos,
& Vizi, 2000). These neurotransmitters act on immune cell receptors, causing the release
of cytokines that upregulate inflammation (Szelényi, 2001). ACTH, adrenocorticotropic
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hormone; CRF, corticotropin-releasing factor; PVN, hypothalamic paraventricular
nucleus; SNS, sympathetic nervous system.

CRF is released by neurons in regions such as the hypothalamic paraventricular
nucleus (PVN), the bed nucleus of the stria terminalis (BST), and central nucleus of the
amygdala (CeA) (Kono et al., 2017), which contribute to the expression of fear and
anxiety (LeDoux, 2000; Shackman & Fox, 2016) and promote hormonal responses to
threat (Herman & Cullinan, 1997). CRF-releasing neurons from these regions project to
VTA and NAc (Dabrowska, Martinon, Moaddab, & Rainnie, 2016; Rodaros, Caruana,
Amir, & Stewart, 2007) (Figure 1), where CRF influences dopamine release and
motivated behavior, but with divergent effects in either region (Hollon et al., 2015), as
discussed further below.
In the rat VTA, uncontrollable foot-shock stress causes CRF release (B. Wang et
al., 2005). Injection of CRF into VTA dose-dependently increases the baseline firing rate
of dopamine neurons (Wanat, Hopf, Stuber, Phillips, & Bonci, 2008), but decreases
phasic dopamine response to food rewards (but not reward-predictive cues) (Wanat et al.,
2013). Further, restraint stress decreases motivation to work for food reward in a
progressive ratio task (Wanat et al., 2013) and biases decision making towards low
effort/low reward choices (Bryce & Floresco, 2016), which can be blocked by a CRF
antagonist injected into VTA (Bryce & Floresco, 2016; Wanat et al., 2013). Thus, CRF
release in VTA appears to decrease reward motivation following stress, likely via
dopaminergic changes.
CRF activity in NAc seems to exert rather different effects on motivated behavior
(Lemos et al., 2012; Peciña, Schulkin, & Berridge, 2006). Injection of CRF into NAc
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increased the ability of Pavlovian reward cues to enhance lever-pressing for sucrose
rewards (Peciña et al., 2006) and caused conditioned place preference alongside
increased dopamine release (Lemos et al., 2012). These results suggest that, unlike in
VTA, CRF release in NAc enhances reward conditioning. However, severe forced-swim
stress abolished the ability of CRF to increase dopamine release, and also switched the
behavioral effect of CRF to conditioned place aversion (Lemos et al., 2012). Thus,
impact of CRF release in NAc appears to be conditional on prior stress exposure.
CRF may exert its influence on mesolimbic functioning by gating the release of
brain-derived neurotrophic factor (BDNF) following stress (Berton et al., 2006; Koo et
al., 2016; Krishnan et al., 2007; Walsh et al., 2014). Numerous studies suggest that
following 10-day social defeat stress, BDNF released from VTA acts on receptors in NAc
to mediate the impact of stress on reward-seeking and social behavior (Berton et al.,
2006; Koo et al., 2016; Krishnan et al., 2007). Even briefer, “subthreshold” social defeat
stress, when combined with phasic, optogenetic stimulation of VTA-NAc neurons,
produced social interaction deficits and increased BDNF levels in NAc (Walsh et al.,
2014). Importantly, CRF antagonism in NAc prior to subthreshold stress and optogenetic
stimulation prevented this increase in BDNF and rescued effects of stress on social
interaction (Walsh et al., 2014). Thus, CRF release may be necessary to produce stressinduced alterations in NAc BDNF and decreased social interaction.
Preliminary human work supports an effect of CRF on reward processing and
behavior. One study examined a single-nucleotide polymorphism (SNP) in the CRHR1
gene that codes for the CRF receptor CRHR1 (Bogdan, Santesso, Fagerness, Perlis, &
Pizzagalli, 2011). Homozygosity for the A allele of this SNP was associated with blunted
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neural response to rewards (indexed by scalp-recorded electrophysiology) under acute
stress (threat of shock). A/A individuals also exhibited a decreased behavioral response
bias under stress. Decreased response bias in this task has been previously associated
with MDD status, and with increased anhedonia symptoms in individuals with MDD
(Pizzagalli, Iosifescu, Hallett, Ratner, & Fava, 2008). Though sample size in the
genotyping study was relatively small (n=84) for detection of a gene by environment
interaction, and the effects warrant replication, these results are concordant with animal
literature suggesting an effect of stress-induced CRF on anhedonia.
In summary, neuroendocrine stress responses may recalibrate mesolimbic reward
processing: CRF appears to decrease reward motivation via actions in the VTA, but
enhances reward conditioning in NAc, except after prior severe stress exposure. CRF
may exert these effects by moderating stress-induced BDNF release. More work in this
domain will be crucial to understanding how HPA axis functioning and mesolimbic
reward circuits coordinate during stress responses, and how dynamics in these systems
contribute to stress-induced anhedonia.
Stress, energy homeostasis, and reward.
Maintaining energy homeostasis—e.g., by regulating feeding and satiety—
requires flexible adjustments to reward seeking (Berthoud, 2012; Hayes & Schmidt,
2016). For example, rodents that have consumed food to satiety exhibit diminished
motivation for food rewards (Colwill & Rescorla, 1985). To accomplish this, energy
homeostasis systems coordinate with the mesolimbic reward system (Cassidy & Tong,
2017) (see below). Although energy homeostasis systems include diverse central and
peripheral signaling pathways involving numerous peptides (Berthoud, 2012), for the
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purposes of this review, we highlight the role of glucagon-like peptide-1 (GLP-1). GLP-1
signaling appears to decrease reward motivation (Hayes & Schmidt, 2016), and these
pathways are activated by stress (Maniscalco et al., 2015)—see below. Thus, GLP-1
pathways and other energy homeostasis systems are well-positioned to mediate stress
effects on anhedonia.
GLP-1-producing neurons originate almost exclusively in the caudal nucleus of
the solitary tract (cNST) in the brainstem (Merchenthaler, Lane, & Shughrue, 1999).
These projections play key roles in decreasing food intake both during satiety
(Maniscalco, Kreisler, & Rinaman, 2012; van Bloemendaal, ten Kulve, la Fleur,
IJzerman, & Diamant, 2014) and following stress (Maniscalco & Rinaman, 2017). GLP-1
signaling appears to decrease the rewarding value of food (S. L. Dickson et al., 2012)
through direct projections to NAc and VTA (Alhadeff et al., 2012) (Figure 1). For
instance, injection of a GLP-1 receptor agonist into rat VTA or NAc reduced lever
pressing for food in a progressive ratio task (S. L. Dickson et al., 2012). Importantly,
GLP-1-induced alterations in motivated behavior extend to alcohol and drug rewards
(Hayes & Schmidt, 2016). For example, GLP-1 agonism in rats reduces the impact of
alcohol reward on conditioned place preference (Shirazi, Dickson, & Skibicka, 2013).
Similar reports have emerged for other drugs, including cocaine and nicotine (Hayes &
Schmidt, 2016). Several studies in rodents suggest that GLP-1 alters reward functioning
by influencing dopaminergic mesolimbic circuitry, although some studies report
decreases and some increases in dopamine activity (Fortin & Roitman, 2017; MietlickiBaase et al., 2014, 2013; X. F. Wang et al., 2015). Taken together, these results suggest
that GLP-1 signaling may decrease motivation for rewards in general.
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GLP-1 signaling pathways are also activated by stress, including restraint and
elevated platform stress (Maniscalco et al., 2015). Notably, peripheral inflammation in
response to immune challenge also appears to activate GLP-1 neurons (Gaykema et al.,
2009), highlighting the need for a multi-systems approach to bridge work on immune
responses and homeostatic energy regulation pathways following stress (see also
Inflammation and reward processing, below). GLP-1 neurons projecting to the PVN also
mediate HPA axis responses to stress (Figure 1), including release of adrenocorticotropic
hormone (ACTH) and glucocorticoids (Ghosal et al., 2017)—see Box 2 and Figure 2.
These results suggest that GLP-1 pathways could interact with other putative mechanisms
of stress-induced anhedonia. Importantly, recent work in rats suggests that GLP-1
signaling is crucial for restraint stress to induce hypophagia (decreased food intake), as an
intraventricular GLP-1 receptor antagonist attenuated the hypophagic effects of restraint
stress (Maniscalco et al., 2015). Given the involvement of mesolimbic reward circuits in
producing GLP-1 mediated hypophagia (Alhadeff et al., 2012), this study suggests that
GLP-1 could play a role in stress-induced alterations in reward behavior more generally.
The possibility that GLP-1 signaling partially mediates the effect of stress on reward
processing merits follow-up.
Not surprisingly, other energy homeostatic pathways may also contribute to
stress-induced anhedonia. For instance, antagonism of a melanocortin receptor (MC4R)
in NAc prevents anhedonic-like decreases in sucrose preference following chronic stress
in mice (Lim, Huang, Grueter, Rothwell, & Malenka, 2012). Indeed, as research on the
links between energy homeostasis systems and reward systems has expanded
considerably in recent years (Cassidy & Tong, 2017), the list of possible stress-anhedonia
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mediators has also expanded. Notably, anhedonia is frequently accompanied by appetite
and weight changes in humans diagnosed with MDD (American Psychiatric Association,
2013). Thus, energy homeostasis systems in general are an exciting target for future
research on stress-induced anhedonia.
Putative Molecular Signaling Pathways to Stress-Induced Anhedonia
In addition to circuit-level mechanisms that could connect stress and anhedonia,
molecular signaling pathways also contribute to motivated behavior (Felger & Treadway,
2017; Russo & Nestler, 2013). Much recent work has focused on the cascade of
inflammatory responses to stress (see Box 2) and possible effects on dopamine synthesis
(Felger & Treadway, 2017). Other molecular signaling pathways are covered elsewhere
(Russo & Nestler, 2013).
Inflammation and reward processing.
Numerous studies suggest that inflammation alters motivated behavior and
mesolimbic function, possibly through dopaminergic changes. Although we highlight
recent work in this domain, a more thorough treatment of this topic is available (see
Felger & Treadway, 2017).
A series of studies in mice suggests that the pro-inflammatory cytokine
interleukin-6 (IL-6), in particular, may be a key contributor to stress-induced anhedonia
(Hodes et al., 2014; Menard et al., 2017; J. Wang et al., 2018). Social defeat stress
produces a ~27-fold increase in peripheral IL-6 (Hodes et al., 2014). Additionally, social
defeat appears to weaken the blood-brain barrier by reducing levels of Cldn5, a cell
adhesion molecule, allowing IL-6 to infiltrate NAc parenchyma and producing
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diminished social interaction (Menard et al., 2017). These studies suggest that stressinduced IL-6 infiltration, in conjunction with synaptic remodeling in NAc (see J. Wang et
al., 2018), contributes to the development anhedonic-like behavior (Hodes et al., 2014;
Menard et al., 2017; J. Wang et al., 2018). Increases in IL-6 and social interaction deficits
were both rescued by bone marrow infusions from IL-6 knockout mice, suggesting that
these immune and behavioral changes are mediated by bone marrow-derived, peripheral
immune cells (Hodes et al., 2014). Interestingly, administration of the plant metabolites
dihydrocaffeic acid (DHCA) and malvidin-3’-O-glucoside (Mal-gluc) blunted IL-6
responses to social defeat stress and promoted resilience to anhedonic-like behaviors
(blunted sucrose preference and decreased social interaction) (J. Wang et al., 2018).
DHCA inhibited IL-6 production via disrupted gene transcription, while Mal-gluc
inhibited synaptic restructuring in NAc, and both changes were necessary to achieve
therapeutic effects (J. Wang et al., 2018). Taken together, this work suggests that
inflammatory responses, together with neurovascular and synaptic changes, promote
susceptibility to anhedonic behavior. Moreover, these exciting studies illustrate how
research spanning multiple systems (e.g., immune response and brain reward systems)
may produce key insights about pathways to stress-induced anhedonia.
Despite this evidence linking inflammatory responses to brain reward systems,
rodent studies on inflammation and dopaminergic function specifically have yielded
mixed results. Rodent studies measuring the impact of interferon-α (IFN-α, a proinflammatory cytokine) on dopamine release have reported either increases or decreases
in dopamine/dopamine metabolites (Felger & Treadway, 2017). These divergent findings
may be partly due to differences in dosing, chronicity, and timeframe of exposure (Felger
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& Treadway, 2017). However, some evidence suggests that recombinant human IFN-α
does not bind to expected targets in rodents (Loftis, Hauser, Macey, & Lowe, 2006), and
inconsistent use of species-specific IFN-α could therefore explain these mixed results in
rodents (Felger & Treadway, 2017). By contrast, a recent study that administered IL-6
found decreased effortful responding for a preferred (vs. freely available) reward
alongside decreased extracellular dopamine in NAc core, as assessed by microdialysis
(Yohn et al., 2016), suggesting that behavioral changes were mediated by alterations in
dopamine release.
Two studies in rhesus monkeys have assessed in vivo dopamine release in
response to inflammation. Chronic administration of IFN-α decreased effort-based, but
not freely available, sucrose consumption (Felger, Mun, et al., 2013) and in vivo
microdialysis in these animals indicated decreased dopamine release in the caudate.
Additionally, inflammation-induced deficits in dopamine release were abolished by
administration of L-DOPA, the precursor to dopamine (Felger, Hernandez, et al., 2015).
This finding suggests that IFN-α administration decreased dopamine release by reducing
synthetic capacity.
In humans, a recent functional magnetic resonance imaging (fMRI) study of
healthy female participants examined the effect of stress-induced inflammation on reward
prediction errors (RPEs; see Box 1) in VS, which includes NAc (Treadway et al., 2017).
First, participants completed a cold pressor task while performing serial subtraction in
front of an experimenter. Blood levels of IL-6 were assessed before and after the stressor.
During a second session, participants completed arithmetic problems of escalating
difficulty while exposed to criticism from an unfriendly, impatient experimenter. They
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then completed a probabilistic reward task during an fMRI scan. Analyses revealed that
stress-induced increases in IL-6 during the first session were associated with diminished
VS BOLD responses to RPEs during the second session, although there was no main
effect of stress on BOLD RPE signals, and no behavioral effects were detected
(Treadway et al., 2017).
An fMRI study of individuals with MDD investigated the association between
resting-state functional connectivity, inflammatory markers, and anhedonic symptoms
(Felger, Li, et al., 2015). Connectivity between VS and ventromedial PFC (vmPFC)
negatively correlated with blood levels of C-reactive protein (CRP), a marker of
inflammation. Furthermore, decreased VS-vmPFC connectivity was associated with
higher anhedonia scores (Felger, Li, et al., 2015). These results suggest that resting-state
fluctuations may capture alterations in the functional architecture of the
corticomesolimbic circuit (see Box 1 and Medial prefrontal cortex regulation of the
mesolimbic circuit) associated with inflammation and anhedonia.
Altogether, these findings suggest that inflammation impacts motivated behavior,
possibly through changes in dopaminergic mesolimbic circuitry. Several plausible
theories have been advanced to characterize these alterations at the molecular level.
Inflammation and dopamine synthesis.
Inflammation may decrease dopaminergic signaling by disrupting the biosynthetic
pathway to dopamine (Felger & Treadway, 2017). Inflammation appears to decrease the
availability of tetrahydrobiopterin (BH4), an enzyme cofactor that is critical at two stages
of dopamine synthesis: a) conversion of phenylalanine to tyrosine, and b) conversion of
tyrosine to L-3,4-dihydroxphenylalanine (L-DOPA), the precursor to dopamine (Box 3).
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To test this hypothesis, researchers have examined cerebrospinal fluid (CSF) and blood
concentrations of phenylalanine, tyrosine, and the phenylalanine/tyrosine (Phe/Tyr) ratio
as indirect measures of dopamine synthesis. The Phe/Tyr ratio was elevated in
individuals receiving IFN-α as a treatment for hepatitis C (Felger, Li, et al., 2013),
suggesting that inflammation impeded the conversion of phenylalanine to tyrosine (see
Box 3). Although promising, interpretation of these findings is limited by small sample
size, especially in the control group (9 individuals). Additionally, in a sample of elderly
persons with chronic low-grade inflammation, elevated tyrosine, but not phenylalanine or
the Phe/Tyr ratio, was associated with reduced motivation (Capuron et al., 2011).
However, tyrosine levels were non-significantly associated with inflammatory markers
(IL-6 and CRP). Thus, the role of inflammation in impeding the conversion of tyrosine to
L-DOPA (see Box 3) remained unclear. Taken together, this important research has
yielded hints that inflammation disrupts dopamine synthesis by decreasing BH4
availability, consistent with some animal work (Kitagami et al., 2003). Given the
potential significance of these findings, additional follow-up is merited.
Inflammation may also decrease dopamine synthesis through the kynurenine
pathway by increasing oxidative stress (Dantzer, 2016)—see Figure 3 (for more detailed
discussion, see Dantzer, 2016; Felger & Treadway, 2017). Importantly, dopamine
neurons are especially vulnerable to inflammatory insult (Block, Zecca, & Hong, 2007).
Moreover, xanthurenic acid, a kynurenine pathway metabolite, inhibits BH4 synthesis
(Haruki, Hovius, Pedersen, & Johnsson, 2016), suggesting that increased kynurenine
production resulting from inflammation could interfere with dopamine synthesis through
BH4 depletion. Consistent with the kynurenine pathway theory, increased quinolinic acid
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(QUIN) levels in CSF were associated with IFN-α treatment for hepatitis C (Raison et al.,
2010), see Figure 3.

Figure 3. Inflammation-induced excitotoxicity through the kynurenine pathway. (A) Proinflammatory cytokines stimulate indoleamine 2,3-dioxygenase (IDO) in peripheral
macrophages, resulting in kynurenine that crosses the blood-brain barrier. (B) Microglia
convert kynurenine to quinolinic acid (QUIN). (C) In turn, QUIN exerts possibly
neurotoxic effects, in part by (D) activating N-methyl-d-aspartate (NMDA) receptors, and
(E) by decreasing glutamate reuptake, which increases glutamate release to potentially
excitotoxic levels (Dantzer, 2016). DA, dopamine; IDO, indoleamine 2,3-dioxygenase;
NMDA, N-methyl-d-aspartate.

Altogether, evidence suggests that inflammation could interfere with dopamine
synthesis, possibly by preventing enzymatic activity in the biosynthetic pathway or by
increasing neurotoxicity. However, whether stress-induced inflammation causes
disrupted dopamine synthesis remains equivocal. Some work has examined the impact of
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stress on dopamine depletion (Cabib & Puglisi-Allegra, 2012), although inflammation
was not assessed. Moreover, it is not yet clear whether stress type (e.g., interpersonal
stress; see (Slavich & Irwin, 2014)) may influence anhedonic responses via changes in
inflammation.
Future Directions in the Study of Stress and Anhedonia
Consistent with our view, recent work suggests that stress contributes to
anhedonic behavior through perturbations across diverse systems and multiple levels of
analysis. For example, pro-inflammatory signaling molecules may cross the blood-brain
barrier to infiltrate brain reward systems directly (Hodes et al., 2014; Menard et al., 2017;
J. Wang et al., 2018), but could also affect motivated behavior through homeostatic
energy regulation pathways (Gaykema et al., 2009). However, despite much promising
work to date on the relations linking stress and anhedonia, important gaps in our
collective knowledge persist.
Anhedonia and key dimensions of stress.
Examinations of stress-induced anhedonia have implemented paradigms that vary
considerably across studies in terms of stress chronicity, severity, controllability, and type
(Anisman & Matheson, 2005), making it difficult to synthesize results across labs. As a
result, the implications of variability in these dimensions of stress are incompletely
understood.
Experiments also vary in the severity of their stress manipulations as a function of
the species under study. In rodents, chronic mild stress commonly entails stressors such
as “strobe light illumination for 1 to 16 h” or “dark cycle (continuous darkness for 24 to
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36 h)” (Tye et al., 2013, p. 542) twice per day for 8-12 weeks. Such stressors would be
unethical to administer to human participants. As a result, human stress inductions
generally take place on the order of minutes, not hours (e.g., Bogdan & Pizzagalli, 2006;
Treadway et al., 2017) and accordingly are not matched for the chronicity (nor, likely, the
severity) of many animal studies. Experimental work in humans assumes that relatively
mild and acute stressors will produce alterations in reward function that are reliably
detectable and qualitatively similar to alterations produced by severe and/or chronic
stress. Yet the actual relation between stress and anhedonic processes could violate these
core assumptions.
The impact of stressor chronicity also remains unclear. It is possible that stressors
produce divergent effects on mesolimbic dopaminergic functioning depending on
chronicity (see Stress and the mesolimbic reward circuit). Yet both acute stressors (e.g.,
death of a loved one) and chronic stress (e.g., ongoing financial difficulties) can lead to
anhedonic symptoms (Keller et al., 2007). The impact of these events on subsequent
symptoms may depend in part on regulatory responses. For certain individuals, such as
those with a ruminative response style (Michael et al., 2007), even acute stressors may
provoke chronic stress responses, leading to long-lasting and relatively inflexible
anhedonic states.
Observational studies of responses to naturally-occurring severe/chronic stressors
could supplement the important experimental work reviewed above. Both avenues of
research are necessary, given the trade-off between experimental control and strength of
causal inference vs. ecological validity. Large observational studies in humans could
distinguish the differential impact of numerous types of stressors. Indeed, preliminary
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evidence suggests that anhedonia may be especially prominent following interpersonal
losses (e.g., death of a loved one or romantic loss) (Keller et al., 2007). Notably, the
aforementioned study assessed the severity of anhedonia relative to other dysphoric
symptoms, rather than an “absolute” measure of anhedonia (Keller et al., 2007). Thus,
more work is needed to understand the impact of dimensions of stress, such as stressor
chronicity, on anhedonia per se. A few important studies have compared the
contributions of acute life events vs. chronic difficulties on broader phenotypes that may
or may not include anhedonia, such as MDD (Muscatell, Slavich, Monroe, & Gotlib,
2009), or on depressive symptom aggregates (McGonagle & Kessler, 1990). However,
such studies rarely examine the links between stress and anhedonia specifically, or indeed
any individual symptoms (for an exception, see Keller et al., 2007). More work in this
domain could help researchers continue to increase the ecological validity of
experimental models of stress and anhedonia.
Finally, anhedonia is a multifaceted construct. Although anhedonia is often
defined with reference to loss of pleasure or motivation (American Psychiatric
Association, 2013), researchers have recently conceptualized anhedonic behavior in
terms of a broader array of motivational and reward processes. Because decision-making
requires the weighing of potential rewards against expected costs (Lima, 1998; Zald &
Treadway, 2017), decreased reward seeking could result from changes to several facets of
this process, e.g., reward devaluation and/or an increase in forecasted effort costs
(Treadway & Zald, 2011). Future experiments can make use of paradigms that
distinguish these facets of reward processing (Zald & Treadway, 2017).
Variability in reward processing and motivated behavior following stress.
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Researchers studying stress and anhedonia must account for a counterintuitive
relationship: Under certain circumstances, stress increases reward motivation and
sensitivity to reward (Mather & Lighthall, 2012; Willner, 2005). Alcohol/substance use
problems and obesity are linked with stress and (at least theoretically) involve increased
reward seeking (Volkow & Wise, 2005), although increased sensation seeking may
predispose individuals towards substance use (A. J. Holmes, Hollinshead, Roffman,
Smoller, & Buckner, 2016), suggesting the importance of individual factors. How can we
reconcile these apparent discrepancies?
One possibility is that certain individuals are more prone to seek out rewards
rather than experience anhedonia in response to stress. Such between-individual
variability is plausible from an evolutionary perspective, e.g. due to fluctuations in
environmental demands that preclude the possibility of a single, “optimal” response
profile (Dingemanse, Both, Drent, & Tinbergen, 2004; A. J. Holmes & Patrick, 2018).
Indeed, sex may be a meaningful individual difference for stress responses: Following a
cold pressor, men responded more quickly and “cashed in” more often in a decisionmaking task, whereas women responded more slowly and “cashed in” less (Lighthall et
al., 2012). Still, between-individual factors are unlikely to fully account for variability in
responses to stress. Some evidence in humans suggests that, within individuals, different
events are likely to provoke more or less prominent anhedonia, and dissociable patterns
of dysphoric symptoms in general (Keller et al., 2007). A comprehensive model of stress
and anhedonia will incorporate both stable tendencies that vary across individuals (Sih,
Bell, & Johnson, 2004) and within-individual variability (e.g., in response to different
types of stress) (Dingemanse et al., 2010).
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Concluding Remarks
Delineating an anhedonic phenotype rooted in etiology represents an important
goal for psychiatric research. Such a phenotype could help to increase homogeneity in
clinical research samples, and the accompanying increase in statistical power could make
it easier to identify critical vulnerability factors for chronic, severe anhedonia. In turn,
identifying vulnerability factors and proximal causes of anhedonia could improve
predictions of conversion to disorder and suggest novel targets for treatment.
Cross-species work has made considerable progress in illuminating plausible
mechanisms that could bridge the occurrence of stress and onset of anhedonia. Yet
seemingly contradictory patterns of results have emerged across lines of research. Better
parsing heterogeneity in stressors and in reward processing could help to decipher
puzzling results and yield crucial insights. Additionally, a unified model is needed to
account for isolated findings across levels of analysis (e.g., molecular signaling, neural
circuitry, behavior, subjective experience), including seemingly discrepant findings (e.g.,
stress decreases the number of spontaneously firing dopamine neurons in VTA, but
increases firing rates).
Furthermore, the full realization of a multi-system, multi-level approach to
psychopathology will require more inter-disciplinary collaboration, drawing on
psychology, neuroscience, immunology, endocrinology, and economics, among other
fields. Unraveling pathways to complex psychiatric phenotypes requires research that
cuts across levels—from genetics to molecular signaling pathways, functional circuits,
cognition, behavior, and culture. We believe that this approach holds the potential to
yield much-needed answers for individuals experiencing debilitating psychiatric illness.
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Box 1. Reward Processing, Dopamine, and the Mesolimbic System
Reward processing recruits diverse circuits spanning numerous regions, including
the basal ganglia, medial prefrontal cortex (mPFC), orbitofrontal cortex (OFC), and
amygdala (Haber & Knutson, 2009). Here, we provide a brief review focused on the
dopaminergic mesolimbic pathway, given its well-established relation to anhedonia
(Russo & Nestler, 2013), although other circuits likely contribute. The stress-initiated
mechanisms described in this review converge on the mesolimbic pathway (see main
text, Figure 1).

Box 1, Figure I. Dopaminergic and mesocorticolimbic circuitry. GABA, γ-Aminobutyric
acid; mPFC, medial prefrontal cortex; NAc, nucleus accumbens; SN, substantia nigra;
VTA, ventral tegmental area.

The mesolimbic pathway consists of dopaminergic neuronal projections from the
ventral tegmental area (VTA) to nucleus accumbens (NAc) (Figure I). Dopamine
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neurons, including those of the mesolimbic pathway, play a key role in reward processing
(Berridge, Robinson, & Aldridge, 2009; Mirenowicz & Schultz, 1994; Schultz, 2016).
Their specific role may vary based on time (Schultz, 2016) and on the particular
population of dopamine neurons (e.g. Howe & Dombeck, 2016). For instance,
researchers have argued that an initial component of the dopamine response is sensitive
to stimulus salience, whereas a subsequent component encodes a reward prediction error
(RPE) (Schultz, 2016). That is, the dopaminergic RPE signal spikes following
unpredicted rewards, and is sensitive to reward value. As rewards become more
predictable (e.g., due to association with predictive cues), dopaminergic firing spikes in
response to reward-predicting cues and is suppressed when expected rewards are omitted
(Schultz, Dayan, & Montague, 1997). Recent evidence suggests that mesolimbic
dopaminergic firing encodes the value of working for a reward, and thus may signal
reward value and influence motivation (Hamid et al., 2016).
Distinct populations of dopamine neurons appear to differentially impact reward
processing vs. locomotion, suggesting heterogeneity of dopamine subpopulations (Howe
& Dombeck, 2016). Dopamine also acts on functionally heterogeneous receptors: D1type receptors, which are excitatory, and D2-type receptors, which inhibit neuronal firing.
Spikes in mesolimbic dopamine activity (e.g., in response to unexpected rewards) excite
the D1 receptor-expressing “direct” pathway, leading to behavioral reinforcement
(Hikida, Kimura, Wada, Funabiki, & Nakanishi, 2010; Kravitz, Tye, & Kreitzer, 2012).
By contrast, suppressed dopaminergic firing disinhibits the D2 receptor-expressing
“indirect” pathway to facilitate learning from non-reward/punishment (Hikida et al.,
2010; Kravitz et al., 2012).
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Activity in the mesolimbic pathway appears key for reward learning and for
anhedonic responses following stress (see Stress and the mesolimbic reward circuit).
However, other dopaminergic projections also likely contribute to reward processing. For
example, the nigrostriatal pathway consists of dopaminergic projections from substantia
nigra to dorsal striatum (Lynd-Balta & Haber, 1994). Dorsal striatal activity appears to
play a relatively larger role in goal-directed and habit-based reward learning, whereas
ventral striatum (including NAc) predominantly contributes to associative learning
(Liljeholm & O’Doherty, 2012).
mPFC is closely interconnected with mesolimbic regions (Haber & Knutson,
2009) (Figure I). mPFC receives dopaminergic projections from VTA (Lidow, GoldmanRakic, Gallager, & Rakic, 1991) and sends glutamatergic projections to NAc (Britt et al.,
2012). The vast majority of NAc neurons are GABAergic (Meredith, 1999), including
fast-spiking interneurons (Pennartz, Groenewegen, & Lopes da Silva, 1994) and
projections to VTA (both direct and indirect through the ventral pallidum) (Haber, 2016).
Connections among these regions form a mesocorticolimbic circuit, which is implicated
the computation of reward value and motivation (Kable & Glimcher, 2007; Liljeholm &
O’Doherty, 2012; Rangel & Hare, 2010). Thus, mPFC is ideally situated to influence
mesolimbic dynamics, either directly (via glutamatergic synapses on NAc interneurons,
or on NAc projections to VTA) or indirectly (via wide-ranging projections of mPFC).
Notably, mesolimbic regions are connected with a host of other regions implicated in
reward processing, including orbitofrontal cortex (OFC), amygdala, and hippocampus
(Haber & Knutson, 2009).
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Box 2. Stress, Inflammation, and the HPA Axis
Although mammalian stress responses are complex, we provide a brief and
schematized review of neuroendocrine and inflammatory responses here (for more
detailed reviews, see Sapolsky et al., 2000; Slavich & Irwin, 2014; Smith & Vale, 2006).
Stress upregulates activity in two key systems: the hypothalamic-pituitary-adrenal (HPA)
axis and the sympathetic nervous system (SNS) (Elenkov et al., 2000). HPA axis
responses originate in the hypothalamic paraventricular nucleus (PVN), which releases
corticotropin-releasing factor (CRF) into the median eminence. CRF binding in the
pituitary gland causes the release of adrenocorticotropic hormone (ACTH) into the blood
(Smith & Vale, 2006). Circulating ACTH reaches binding sites in the adrenal cortex,
causing the release of glucocorticoids (in humans, primarily cortisol) (Smith & Vale,
2006). Glucocorticoids promote a variety of effects at numerous sites of action, including
boosted glucose concentration in the bloodstream, which provides fast energy resources
to cope with potential threat (Sapolsky et al., 2000).
At the same time, sympathetic nervous system projections from the brainstem
release catecholamines (including norepinephrine, epinephrine, and dopamine) at
peripheral sites (including lymphoid organs, such as the thymus, spleen, and lymph
nodes) (Elenkov et al., 2000). Cathecholamines then act on immune cell receptors at
these sites, causing the release of cytokines that upregulate inflammation (Szelényi,
2001).
Broadly speaking, glucocorticoids suppress inflammatory cytokine activity
(Sapolsky et al., 2000) that might interfere with “fight or flight” behavioral coping
(Slavich & Irwin, 2014). However, as glucocorticoid responses wane, inflammation may
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produce “sickness behaviors” (e.g., decreased feeding and socializing) which are thought
to facilitate recovery processes (e.g., wound healing) (A. H. Miller & Raison, 2016;
Raison & Miller, 2016).
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Box 3. Inflammation May Inhibit Dopamine Synthesis via BH4 Oxidation
Inflammation may impede the biosynthetic pathway to dopamine. For a
detailed review, see Felger and Treadway (2017). Briefly, dopamine synthesis requires
the conversion of phenylalanine to tyrosine by phenylalanine hydroxylase (PAH). A
second enzyme, tyrosine hydroxylase (TH), converts tyrosine to L-DOPA, the human
precursor to dopamine. For these conversions, both enzymes require the cofactor BH4
(Figure I).

Box 3, Figure I. Inflammatory disruption of dopamine synthesis through BH4 oxidation.
(A) Dopamine synthesis requires the conversion of phenylalanine to tyrosine by the
enzyme PAH. A second enzyme, TH, converts tyrosine to L-DOPA, the human precursor
to dopamine. For these conversions, both enzymes require the cofactor BH4. (B) BH4
facilitates production of NO by the enzyme iNOS. In the absence of BH4, iNOS increases
production of a reactive oxygen species, superoxide (O2-). (C) NO and O2- react to
produce peroxynitrite (ONOO-), a powerful oxidant. BH4 is susceptible to oxidation by
peroxynitrite and O2-, which further decreases BH4 availability. (D) Inflammation may
drive BH4 oxidation by increasing the activity of iNOS. BH4, tetrahydrobiopterin; iNOS,
inducible nitric oxide synthase; L-DOPA, L-3,4-dihydroxyphenylalanine; PAH,
phenylalanine hydroxylase; TH, tyrosine hydroxylase.
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BH4 also facilitates production of nitric oxide (NO) by nitric oxide synthases (NOSs). In
the absence of BH4, NOSs increase production of a reactive oxygen species, superoxide
(O2-). BH4 is susceptible to oxidation by O2-. Furthermore, NO and O2- react to produce
peroxynitrite (ONOO-), a powerful oxidant, which may cause neuronal death in addition
to BH4 oxidation (Sharma & Nehru, 2015). Thus, initial BH4 depletion could cause still
greater BH4 deficits through oxidative loss (Figure I).
Inflammation may drive BH4 oxidation by increasing the activity of inducible
NOS (iNOS), an NOS type produced in peripheral macrophages and brain glial cells
(Galea, Feinstein, & Reis, 1992) (Figure I). Accordingly, one study of rats suggests that
peripherally-administered IFN-α decreases brain levels of BH4 and dopamine through
NO that is thought to cross the blood-brain barrier (Kitagami et al., 2003).
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Chapter 3: Key Dimensions of Stress and
Contributions to Anhedonia
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Abstract
Although past work suggests a link between stress exposure and anhedonia
(Keller et al., 2007; Pizzagalli, 2014), the types of stressors that most strongly promote
anhedonia remain unknown. A clearer understanding of which types of stress are most
associated with anhedonia in humans could inform preclinical models and further
elucidate the etiology of anhedonia. Thus, the present study applied Bayesian modeling
techniques to investigate which dimensions of stress are mostly closely associated with
anhedonic symptoms. To do so, we compiled life stress interview data from multiple
studies that assessed stressor severity, chronicity, dependence on participants’ behavior,
and interpersonal focus. Unexpectedly, analyses uncovered no evidence that these
stressor characteristics were substantially associated with anhedonic symptoms. Instead,
the best-fitting model treated all stressors equally, and number of stressors endorsed
within a 6-month time window predicted anhedonic symptoms. Based on the posterior
estimates from this relatively simple model, the impact of each individual stressor on
anhedonic symptoms was modest: Each stressor endorsed was associated with an
increase of approximately 0.48 on the MASQ Anhedonic Depression subscale (overall
SD = 19.18). More work is needed to assess whether this result holds in larger samples,
while also examining other potentially important dimensions of stress and other (e.g.,
narrower) time windows.
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Introduction
Substantial cross-species work suggests a link between stress and anhedonia
(Pizzagalli, 2014; Russo & Nestler, 2013; Stanton, Holmes, Chang, & Joormann, 2019).
However, the types of stress that most strongly promote anhedonia per se, rather than a
broader phenotype that includes anhedonia, such as major depressive disorder (MDD),
are unknown. Investigating which types of stress are most associated with anhedonia
would inform both etiological understanding of anhedonia and methodological practice.
For example, if chronic stress is most strongly associated with anhedonia, this outcome
would suggest that repeated activation of biological stress responses contributes to the
onset of symptoms more strongly than acute stress responses. Additionally, a detailed
understanding of how stressor types differentially predict anhedonia could inform the
design of ecologically-valid stress manipulations in both humans and nonhuman animals.
Examinations of stress-induced anhedonia have varied considerably in the
chronicity, severity, controllability, and type of stress implemented (Anisman &
Matheson, 2005), but the implications of variability in these dimensions of stress are
incompletely understood. Findings from one study in humans (Keller et al., 2007)
suggested that anhedonia may be especially common following some types of stressors
(e.g., death of a loved one or romantic loss) relative to others. This study examined the
contribution of stressors to individual depressive symptoms in a large sample of twins
who reported experiencing a dysphoric episode in the past year. However, this design
tested the relative impact of different categories of stress, while the impact of stress
severity remained unclear. Furthermore, the analysis examined the impact of stress on
patterns of symptoms, rather than focusing on individual symptoms, such as anhedonia
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(Keller et al., 2007). Follow-up work is needed to a) investigate the replicability of these
results, and b) extend them by investigating the (possibly interactive) impact of severity
and chronicity as well as other important dimensions of stress.
Although few studies have focused on anhedonia per se, researchers have devoted
considerable effort to examining how dimensions of stress contribute to MDD (see
Hammen, 2005), MDD subtypes (e.g., Harkness & Monroe, 2006), or categories of MDD
symptoms (e.g., somatic vs. cognitive symptoms; Monroe, Harkness, Simons, & Thase,
2001). As a result, prior work has identified several dimensions of stress that appear to
contribute to the onset of depressive symptoms. In general, stressors of greater severity
are associated with higher risk for MDD onset (Kendler, Karkowski, & Prescott, 1998).
Additionally, higher numbers of stressors endorsed within the same month increase risk
for MDD onset (Sullivan, Kessler, & Kendler, 1998), suggesting a possible effect of
chronicity. However, the literature on stressor chronicity and MDD is mixed, with some
studies finding that chronic stressors are more predictive of depressive symptoms
(McGonagle & Kessler, 1990), some finding that acute events are more predictive
(Muscatell et al., 2009), and some finding no significant differences (Rojo-Moreno,
Livianos-Aldana, Cervera-Martínez, Dominguez-Carabantes, & Reig-Cebrian, 2002).
This inconsistent literature may at least partly reflect differences in methodology, since
time thresholds for determining chronic stress have varied from 4 weeks (Muscatell et al.,
2009; Rojo-Moreno et al., 2002) to 1 year (McGonagle & Kessler, 1990). Additionally,
stressors that are judged to be dependent—that is, plausibly influenced by the
participant’s own behavior—are more strongly associated with MDD onset than likely
independent events, after controlling for stressor severity (Kendler et al., 1999). Some
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evidence also suggests that stressors whose primary focus is interpersonal may contribute
more strongly to depressive symptoms, at least for a subset of individuals who are
especially sensitive to interpersonal stress (Hammen, Marks, Mayol, & DeMayo, 1985).
Despite knowledge about the types of stress that increase risk for the onset of
MDD as a syndrome, little work has focused on the types of stress that predict anhedonia
specifically. As noted above, one study examined the impact of different categories of
stressors on patterns of MDD symptoms (Keller et al., 2007). However, this study did not
address the severity of stress exposure or of anhedonia (only presence or absence) and did
not examine past predictors of MDD status, such as stressor independence or
interpersonal focus. Additionally, although nonhuman animal models of anhedonia tend
to use chronic stressors (Anisman & Matheson, 2005; Russo & Nestler, 2013) the role of
stress chronicity in human anhedonia remains unclear. Thus, additional work is needed to
determine whether the stressor characteristics that most strongly predict MDD—which
may or may not include anhedonia as a symptom (American Psychiatric Association,
2013)—are also predictive of anhedonia per se.
To adequately assess stressor characteristics, detailed life stress interviews may
provide the most detailed and comprehensive data. While stress checklists (e.g., Brugha
& Cragg, 1990; T. H. Holmes & Rahe, 1967) are readily scalable to large sample sizes
due to brevity and low implementation cost, they may omit potentially relevant
information. As others have noted (Harkness & Monroe, 2016), checklists: a) often miss
crucial life events, possibly because they include a restricted set of life events and often
do not allow for the reporting of more than one event in the same category; b) rely on
participants’ subjective interpretation of event severity (if they assess severity at all),
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thereby reducing measurement standardization and conflating stress exposure with stress
responses; c) generally do not contain detailed information about event timing, rendering
the selection of time windows and clarification of temporal precedence more difficult;
and e) tend not to include ratings of chronicity, dependence, or interpersonal focus, which
may be relevant to the impact of stress on anhedonia (see above). By contrast, the Life
Events and Difficulties Schedule (LEDS-2; Bifulco et al., 1989) is a life stress interview
that inquires about a wide range of acute and chronic stressors; uses rating panels that are
blind to diagnostic status to assess stressor severity, independence, and interpersonal
focus, rather than relying participants’ judgments; and guides severity ratings using
standardized anchors for each stressor. The LEDS also yields information on stressor
timing. Thus, there are a priori reasons to expect that the detailed information provided
by an intensive stress interview may be needed to assess which stressors are most
associated with anhedonia. However, collecting a sufficient sample of interview data
presents a particular challenge, since administering the LEDS requires considerable
expertise, resources, and time.
Additionally, to model the effects of several potentially relevant stressor
characteristics requires an analytic strategy capable of handling complex models with
numerous parameters. Bayesian approaches are especially suited to estimating models
with many parameters (Gelman et al., 2013). Furthermore, Bayesian approaches
intuitively account for uncertainty when estimating effects, since they describe the
credibility of parameter values using a posterior probability distribution, after taking both
prior beliefs and the observed data into account (e.g., as opposed to a point estimate that
maximizes the likelihood of the data). A hierarchical model may be especially suited to
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characterize stress data, since stressor characteristics are thought to be interrelated—e.g.,
interpersonal stressors are assumed to be usually dependent on participants’ behavior
(Kendler et al., 1999). In addition, some stressor subtypes may be relatively rare, and
hierarchical modeling would allow for information about one category of stressors (e.g.,
chronic stressors) to inform estimates for a particular subcategory for which there may
exist few examples (e.g., chronic, dependent, noninterpersonal stressors). However, to
our knowledge, Bayesian hierarchical modeling has not been applied to the question of
which stressor characteristics are most linked to anhedonia.
To address the empirical gaps described above, we examined the contributions of
key stress dimensions to anhedonia using intensive interview data compiled from
multiple prior studies. Using Bayesian hierarchical modeling, we constructed a model to
evaluate the contributions of stressor severity, chronicity, independence, and
interpersonality (interpersonal vs. noninterpersonal focus) to anhedonic symptoms.
Additionally, we compared the outcome of the resulting “full” model to a “simple sum”
model that treats all stressors equally and uses number of stressors endorsed to determine
the impact on anhedonic symptoms. We hypothesized that, if the contribution of stress to
anhedonic symptoms mirrors the work that has been conducted on stress and MDD, then
dependent, interpersonal stressors (Hammen et al., 1985; Kendler et al., 1999) would
have the greatest impact on anhedonic symptoms. As a competing hypothesis, we
considered whether a model that treats all stressors as equal might better account for
anhedonic symptoms (given the stress dimensions tested and the available data).
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Methods
Sample Composition
The present sample comprises four datasets from studies conducted by Kate
Harkness and colleagues (see Harkness et al., 2010; Harkness & Monroe, 2006). Table 1
characterizes each of these four samples in terms of age, sex, and diagnostic status.
Because differences in diagnostic category, age, sex, and study protocol could influence
our results, we controlled for these factors in each model (see Model structure). After
excluding individuals with missing stress interview or anhedonia self-report data, and
individuals with diagnoses besides MDD or remitted MDD, the final sample for this
analysis consisted of 635 individuals. Of this sample, 82.4% of individuals identified as
white or Caucasian, 1.6% as Black or Afro-Canadian, 8.7% as Asian or Asian-Canadian,
0.8% as First Nations (indigenous peoples of Canada), and 5.5% race unknown or not
reported. Additionally, 1.3% of individuals identified as Hispanic or Latinx.

Table 1. Sample characteristics by study
Study

Age

Sex (n)

Diagnostic Category

Range

M (SD)

Female

Male

HC

MDD

rMDD

ARP

13-21

15.55 (1.46)

83

44

50

74

3

BSP

15-33

20.97 (3.13)

206

59

104

143

18

LSD

18-57

36.77 (10.56)

74

None

None

74

None

PAD

12-21

16.31 (2.23)

127

42

71

76

22

Total:

12-57

20.49 (7.70)

490

145

225

367
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Note. ARP = Adolescent Risk Project; BSP = Blue Sky Project; LSD = Life Stress and
Depression; PAD = Predictors of Adolescent Depression. HC = healthy control; MDD =
Major Depressive Disorder; rMDD = remitted Major Depressive Disorder.
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Materials and Measures
Life stress interview. The Life Events and Difficulties Schedule (LEDS-2;
Bifulco et al., 1989) is a semi-structured interview and rating system that assesses recent
stressful life events (over the 5-year period prior to the interview, for the present data).
The LEDS inquires about events from 10 domains: education, occupation, housing,
finances, role changes, legal issues, health, romantic relationships, other relationships,
and deaths. All interviews were audiotaped, and these tapes were used by a research
assistant to prepare vignettes of each event, omitting information about diagnostic status
and participants’ emotional reactions to events. Using the vignettes, a panel of 2-4 blind
raters coded the severity of each event according to a set of standardized criteria. Severity
was rated on a 5-point scale in terms of long-term threat to the individual (1 = marked, 2a
= high moderate, 2b = low moderate, 3 = some, 4 = little/none), anchored by examples
for each severity level of each stressor. This procedure allows for measurement of stress
exposure per se, avoiding potential bias due to knowledge of diagnosis or participant
reactions to stress. Discrepancies among raters were discussed to arrive at a consensus
rating, which was used for all analyses.
The same panels also rated event independence (whether a participant’s own
behavior likely influenced an event). Events judged to be entirely or almost entirely
independent of a participant’s behavior were coded as likely independent (e.g., lost job
due to factory closing); otherwise, the event was coded as plausibly dependent (e.g., quit
job).
Additionally, panels rated interpersonality, where an event was coded as
interpersonal only if the stressor centered primarily on an interpersonal relationship (e.g.,
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divorce). Events that did not primarily focus on a relationship were coded as
noninterpersonal, even if they involved another person (e.g., receiving a failing grade,
although that grade was assigned by a teacher). Notably, many potentially
noninterpersonal events could be coded as interpersonal if a relationship was the key
element (e.g., being publicly berated by a teacher over a failing grade).
Anhedonia measure. Anhedonia was assessed using the Anhedonic Depression
subscale of the Mood and Anxiety Symptom Questionnaire (MASQ; Watson, Weber, et
al., 1995). The MASQ has previously exhibited good internal consistency in clinical and
non-clinical samples (α > .80) and both convergent and discriminant validity (Watson,
Clark, et al., 1995).
Analytic Approach
We adopted a Bayesian hierarchical linear modeling approach to characterize the
association between stress dimensions and anhedonia. The Bayesian framework is
preferred for the present application because: a) the focus is on estimating parameter
values themselves, rather than estimating the likelihood of the data given a null
hypothesis; b) Bayesian inference provides intuitive quantification of uncertainty for
parameter estimates; and c) Bayesian approaches are relatively well-suited to fitting
complex models with many parameters (Gelman et al., 2013).
Bayesian models start with a prior distribution that represents our confidence in
the possible values of the parameters of interest, before taking the data into account. An
example of a parameter might be a regression weight for the effect of interpersonal stress
severity on anhedonia. Some function is selected (e.g., a linear function) to estimate the
likelihood of the data for all plausible parameter values. Finally, using Bayes’ Rule,
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analyses take into account prior expectations and also the likelihood of the data,
producing posterior distributions for each parameter. These distributions describe our
confidence in parameter values, given the priors used and the observed data (Gelman et
al., 2013; Kruschke, 2014).
We employed Hamiltonian Markov Chain Monte Carlo (Hamiltonian MCMC) to
sample from the posterior distribution. Hamiltonian MCMC is a widely used method that
a) does not assume a particular shape for the posterior, and b) can generate representative
samples from the posterior of even highly complex models (Gelman et al., 2013;
Kruschke, 2014). To implement Bayesian modeling via Hamiltonian MCMC, models
were defined using the Stan programming language (Stan Development Team, 2021) via
interface with R version 3.5.3 (R Core Team, 2020). Model fitting was conducted using
four chains of 10,000 steps each, with a warm-up of 500 steps.
When evaluating the estimated posteriors for a given model, we here consider a
parameter to have contributed substantially to the outcome if the 95% high density
interval (HDI) for the posterior of that parameter does not contain zero.
Data Preparation
For LEDS data, acute life events rated as having “little to no long-term threat” to
the individual can include events that are often viewed as beneficial, such as a marriage
(Bifulco et al., 1989). Thus, these events were excluded from analysis. The resulting
severity ratings were re-coded such that higher values indicated increasing severity: some
long-term threat = 0, low moderate = 1, high moderate = 2, and marked = 3. Similarly,
chronic difficulties rated as “very mild” were dropped, and the resulting ratings were recoded to fit the same scale as acute life events: mild = 0, low moderate = 1, high
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moderate = 2, and marked = 3. Independence ratings were dichotomized in accordance
with prior work (Harkness et al., 2010).
Because prior work suggests that events within a 6-month time window prior to
MDD onset are of the greatest etiological relevance (Harkness et al., 2010; Kendler et al.,
1998), we examined stressors within a 6-month time window prior to each participant’s
interview date, when the MASQ was administered. Chronic difficulties were included if
any part of the difficulty’s time span included the 6-month window of interest.
We sorted participants into age groups rather than treat age as a continuous
variable, since we do not necessarily expect a linear effect of age. To facilitate
comparisons with prior work (Harkness et al., 2010), we used the following age groups:
a) adolescence (ages 12-17); b) young adulthood (ages 18-29); c) middle adulthood (ages
30-49); and d) upper middle adulthood (ages 50-65).
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Model Structure

Figure 1. “Full” model schematic diagram.
“Full” model. This study primarily aimed to disentangle the possible effects of
stressor chronicity, severity, independence, and interpersonality. Thus, we constructed a
model—referred to here as the “full” model—that attempts to account for these
dimensions of stress when predicting anhedonic symptoms. See Figure 1 for a schematic
summary of the “full model” structure, and Appendix A for a more detailed diagram. To
predict anhedonia score for each participant, the “full model” included a) an overall
intercept, added to b) summed values, one for each stressor endorsed by that participant,
which were weighted based on the characteristics of each particular stressor, and c)
parameters for age group, sex, and study protocol. Overall intercepts were fit for each
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diagnostic category; thus, the model estimated the impact of other effects over and above
diagnostic status. The weight for each stressor was defined as the sum of two parameters:
a) a term that was added when the stressor was present, regardless of stressor severity;
and b) a term that was multiplied by the stressor severity value (0-3). Each of these two
parameters was influenced hierarchically by: 1) whether the stressor was rated as
interpersonal vs. non-interpersonal; b) whether the stressor was plausibly dependent vs.
likely independent; and c) whether the stressor was an acute life event or chronic
difficulty. Because some stressors were missing independence or interpersonality ratings
(see Descriptive Statistics, below), missingness was treated as an additional data category
for these variables.

Figure 2. “Simple sum” model schematic diagram.
“Simple sum” model. For comparison purposes, we also fit a model that accounts
only for stressor presence/absence. See Figure 2 for a minimal schematic of this “simple
sum” model, and Appendix A for a more detailed diagram. To predict anhedonia score
for each participant, the “simple sum model” included a) an overall intercept, added to b)
a single parameter multiplied by the sum number of stressors endorsed by the participant
within the time window, regardless of stressor characteristics, and c) parameters for age
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group, sex, and study protocol. As in the “full model,” overall intercepts were fit for each
diagnostic category.
Priors. For all models, 𝑦𝑖,𝑔 ~ skew_normal(𝑥𝑖 , 𝜔𝑔 , 𝛼𝑔 ), where 𝑥𝑖 represents the
location value for subject 𝑖, 𝜔𝑔 represents the scale parameter for diagnostic group 𝑔, 𝛼𝑔
represents the skew parameter for diagnostic group 𝑔, and 𝑦𝑖,𝑔 represents the anhedonia
score for subject 𝑖 from diagnostic group 𝑔. A skew-normal prior was applied here to
account for skew in the data, since individuals in the healthy control group were skewed
towards lower anhedonia scores, and individuals in the MDD group were skewed towards
higher scores. Priors for 𝜔𝑔 were set for each diagnostic group 𝑔, where
𝜔𝑔 ~ normal(SD𝑔 , 1) and SD𝑔 indicates the empirical standard deviation of anhedonia
scores for diagnostic group 𝑔. For the skew parameter, 𝛼𝑔 ~ normal(0,1) for each
diagnostic group. The location value 𝑥𝑖 was defined as the sum of 𝛽 values for each
subject 𝑖 (see Figure 1 below for a schematic representation and Appendix A for more
detail).
At the 𝛽 level of each model, an overall intercept 𝛽0 for each diagnostic group
was included, and 𝛽0,𝑔 ~ normal(M𝑔 , SD𝑔 ∗ 5) where M𝑔 is the empirical mean of
anhedonia scores for group 𝑔. For 𝛽 parameters for age, sex, and study protocol, normal
priors were specified with mean of 0 and variance of 1. In the “simple sum” model, an
additional 𝛽 parameter was added to capture the impact of number of stressors endorsed,
for which a normal prior was specified with mean of 0 and variance of 1.
In the “full” model, priors for parameters at the 𝜖 level were specified as follows:
𝜖𝑐 ~ normal(0,1) for each type of chronicity 𝑐 (acute, chronic). At the 𝛿 level, priors
59

were specified as follows: 𝛿𝑑,𝑐 ~ normal(𝜖𝑐 , 1) for each type of independence 𝑑
(possibly dependent, likely independent, missing independence rating) and chronicity 𝑐.
Finally, at the 𝛾 level, priors were specified as follows: 𝛾𝑝,𝑑,𝑐 ~ normal(𝛿𝑑,𝑐 , 1) for each
type of interpersonality 𝑝 (noninterpersonal, interpersonal, missing interpersonality
rating), independence 𝑑, and chronicity 𝑐.
Results
Descriptive Statistics
On the LEDS, participants endorsed a total of 2,314 stressors (M = 3.64 stressors
per participant, SD = 3.11) that met criteria for inclusion (see Data Preparation). Of
these, 243 were missing interpersonality ratings (10.5% of all stressors) and 89 were
missing independence ratings (3.6% of all stressors). Prevalence of particular types of
stressors are listed in Table 2.
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Table 2. Stressor prevalence by stressor type
Stressor Type

Total Count

Per Participant Count
M

SD

983

1.55

1.71

1,331

2.10

2.09

Possibly dependent

1,276

2.01

2.16

Likely independent

954

1.50

1.56

1,222

1.92

1.97

849

1.34

1.59

1,203

1.89

1.83

Low moderate

601

0.95

1.21

High moderate

378

0.60

0.96

Marked

132

0.21

0.61

Chronicity
Chronic difficulty
Acute life event
Independence

Interpersonality
Noninterpersonal
Interpersonal
Severity (long-term threat)
Some

For the anhedonia subscale of the MASQ, the mean score for the total sample was
69.23 (SD = 19.18). Details by diagnostic category are listed in Table 3.

Table 3. MASQ Anhedonic Depression subscale score by diagnostic category
Diagnostic Category

M

SD

HC

49.95

11.44

MDD

81.26

12.78

rMDD

67.40

13.12

Note. HC = healthy control; MDD = Major Depressive Disorder; rMDD = remitted Major
Depressive Disorder.
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Model Fitting
Before fitting the models to the data, we confirmed that each model worked as
expected by fitting them to simulated data. The simulated dataset was constructed by
using the independent variables from the actual dataset, where the dependent variable
(anhedonia score) was replaced with fictitious data that were computed to include
arbitrary effects of certain stressor types (e.g., an effect of chronic, dependent,
interpersonal stress) or control variables (e.g., age group). Thus, the simulated data
included the real-world stressors endorsed by participants, so that the relative prevalence
of stressor types would remain realistic. Models were able to extract effects from
simulated data as expected. When fit to the actual, observed data, Rhat < 1.01 for each
parameter across both models, suggesting convergence. Additional diagnostics (e.g.,
autocorrelation and density plots for each parameter) are available in Appendix B.
To evaluate relative model fits, we applied leave-one-out cross-validation with
Pareto-smoothed importance sampling (PSIS-LOO; Vehtari, Gelman, & Gabry, 2017) to
calculate the expected log pointwise predictive density (ELPD). The difference in ELPD
between the “simple sum” and “full” models was -324.8, approximately 34.4 standard
errors from zero, suggesting that the “simple sum” model would be expected to better
predict novel data.
Parameter Estimates
“Full” model. See Figures 1 and 2 for visualizations of the estimated posterior
distributions for parameters that index the impact of stressors on anhedonic symptoms in
the “full” model. Figure 1 contains estimates for parameters that index the impact of
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stressor presence per se—that is, whether the participant endorsed that stressor, regardless
of how severe the stressor was rated. Figure 2 contains estimates for parameters that
represent the linear impact of stressor severity. Notably, for each of these parameters, the
95% high density interval (HDI) contains zero. Thus, based on model estimates, these
parameters are unlikely to exert substantial predictive power with respect to anhedonic
symptoms. These results provide no evidence that the stressor types assessed (severity,
chronicity, independence, and interpersonality) contribute to anhedonia, after accounting
for diagnostic status, age, sex, and study protocol. For additional model diagnostics,
including posterior estimates for other parameters, see Appendix B.
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Figure 1. Posterior estimates for “full” model parameters that index stressor
presence/absence. Thin lines denote 95% high density interval (HDI); thick lines denote
90% HDI; points denote the median of posterior samples.
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Figure 2. Posterior estimates for “full” model parameters that index the linear impact of
stressor severity. Thin bands denote 95% high density interval (HDI); thick bands denote
90% HDI; points denote the median of posterior samples.
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“Simple sum” model. The “simple sum” model specified only one parameter to
account for the effect of stress on anhedonic symptoms, treating all stressors as equal.
Figure 3 visualizes the posterior estimate for this parameter. Notably, the 95% HDI did
not contain zero, suggesting that number of stressors endorsed within the time window
(regardless of stressor attributes) significantly predicted anhedonic symptoms (median =
0.48, 95% HDI [0.14, 0.81]). The median of the posterior samples was 0.48, suggesting
that each stressor endorsed was associated with an increase of approximately 0.48 on the
MASQ Anhedonic Depression subscale. For additional model diagnostics, including
posterior estimates for other parameters, see Appendix B.

Figure 3. Posterior estimate for the stress parameter of the “simple sum” model. Thin
bands denote 95% high density interval (HDI); thick bands denote 90% HDI.
Discussion
This study applied Bayesian modeling techniques to investigate which dimensions
of stress are most closely associated with anhedonic symptoms. We compiled samples
from multiple studies that used the LEDS life stress interview, which assessed stressor
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severity, chronicity, independence, and interpersonal focus. However, we uncovered no
evidence that any of these characteristics significantly predicted anhedonic symptoms.
Analyses suggested that the best-fitting model was the simplest model, which treated all
stressors equally. Based on posterior estimates from this model, each stressor endorsed
within the time window (6 months prior to interview) produced a modest increase in
anhedonic symptoms.
Several plausible explanations could account for why the “full” model failed to
identify any stressor dimensions that are especially linked with anhedonia. One
possibility is that this investigation was underpowered to characterize the specific
subtypes of stress examined here. For instance, there may not be enough examples of
chronic, severe, dependent, interpersonal stress to estimate the impact of this particular
type of stress. Indeed, based on estimates from the “simple sum” model, the impact of
stress on anhedonic symptoms is expected to be fairly modest: Each stressor endorsed
was associated with an increase of approximately 0.48 on the MASQ Anhedonic
Depression subscale, where the overall standard deviation in anhedonia scores was 19.18.
Although the hierarchical design of the “full” model was designed to mitigate the
problem of rare stress subtypes, this strategy may not have been enough to overcome
sample size limitations. Thus, a larger sample size may be needed to detect potentially
subtle effects of stressor characteristics.
However, a failure to detect significant effects could also be due to suboptimal
model specification. A differently specified model might be capable of extracting effects
of stressor characteristics on anhedonia, if such effects exist. For example, in the “full”
model, we specified a linear effect of severity. Yet perhaps a nonlinear effect of stressor
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severity would better fit the data, e.g., in which only the most severe stressors contribute
to anhedonia risk. Testing other model specifications could therefore be a useful future
direction.
Additionally, our investigation of the impact of stress severity may have been
limited by the stressors that are assessed on the LEDS. For reasons of feasibility, no selfreport assessment of stress can inquire about every possible stressful occurrence, no
matter how minor. Thus, to be assessed via the LEDS, stressors must necessarily pass
some threshold of severity. It is possible that once life experiences cross a given
threshold, they exert similar effects on anhedonia, and the LEDS does not inquire about
enough experiences on the less-severe side of this threshold to distinguish between
impactful and non-impactful stressors.
Our measurement of stressor chronicity may also be overly narrow. Here, stressor
chronicity referred to the time span over which a particular stressor unfolded (e.g.,
financial concerns that lasted for months). However, numerous acute stressors of
different types, experienced over a relatively brief time window, could also be considered
more chronic stress exposure than a single event. Indeed, results from the “simple sum”
model indicate a non-zero linear slope for number of stressors endorsed within a 6-month
time window, such that a greater number of stressors was associated with more severe
anhedonia. Thus, in the sense that more stressors are linked to more severe illness, stress
chronicity (when considering all stressors together, rather than the chronicity of a single
stressor) could be said to contribute to anhedonia.
Notably, we examined the impact of key stress dimensions on severity of
anhedonic symptoms. Many of the stress dimensions tested here were identified based on
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research that focused on MDD onset. Thus, differences between our findings and those of
the literature on stress and MDD could be accounted for in several ways. First, an
individual may meet for MDD without endorsing anhedonia (American Psychiatric
Association, 2013), so that MDD and anhedonia are not synonymous. Additionally, prior
work has generally examined MDD onset rather than MDD severity. In the present study,
we hypothesized a dose-response relation, such that more stress of a given type would be
expected to predict higher anhedonia scores, even after accounting for diagnosis. In
addition to temporal precedence, such a dose-response relation would be consistent with
a causal effect. Here, we found a dose-response relation such that a greater number of
stressors endorsed within the 6-month time window was linked with more severe
anhedonic symptoms, when all stressors were treated as equal. Finally, earlier work
examined stressors that occurred in a time window prior to MDD onset. In the present
analysis, we considered stressors in the 6 months prior to assessment of anhedonia
severity using the MASQ, which took place following MDD onset for individuals with
MDD. In doing so, we examined stressors that were temporally proximal to the
assessment of anhedonic symptoms, whereas using a pre-onset window would involve
investigating more distant events for individuals with a longer course of illness. However,
with this caveat in mind, future work could investigate whether the current pattern of
results holds if only individuals with MDD are considered, and the time window is
limited to events prior to MDD onset.
The present analysis raises questions that could be addressed in future research.
First, additional studies could test whether the effects of certain stress dimensions are
moderated by factors such as age, and sex, and early-life stress exposure. For example,
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prior work suggests that sex differences in rates of stressful events prior to MDD onset
are strongest in young adulthood (Harkness et al., 2010). Furthermore, key studies in
individuals with MDD have been conducted using entirely female-assigned-at-birth
samples (e.g., Kendler et al., 1999). Additionally, evidence from multiple lines of
research suggests that early-life stress may increase interactions between peripheral
inflammation and key neural circuitry, thereby elevating risk for a host of mental and
physical disorders (Nusslock & Miller, 2016). Thus, early-life stress could also plausibly
moderate the impact of stress on anhedonia. In the present study, we avoided including
interaction terms for age, sex, early-life stress, and diagnostic status to maximize the
comparability of the two models, since the “simple sum” model would require only an
interaction with number of stressors endorsed, whereas examining interactions in the
“full” model would necessitate dozens of additional parameters. However, investigating
potential moderators represents an important area of future study.
The results of the present analysis suggest that, when examining the link between
stress exposure and anhedonia, accounting for the number of stressors endorsed provides
a more parsimonious and predictive model than one which accounts for stressor severity,
independence, interpersonal focus, and chronicity. However, we take care to note that
these results do not, by themselves, support the use of checklist measures over stress
interviews. Of note, stress checklists often provide a very limited accounting of life
stressors owing to their relative brevity, and tend to lack fine-grained information about
stressor timing, rendering it difficult to establish temporal precedence. However, our
results call into question the utility of assessing certain dimensions of stress when
considering the impact on anhedonia severity (but not MDD onset, which was not
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investigated here). Further investigation is needed in a larger sample to verify the results
obtained here.
Despite these results, additional work is needed that uses detailed life stress
information to predict anhedonic severity. Follow-up studies in larger samples could help
to verify the present finding that number of stressors, rather than particular types of
stress, may best account for variance in anhedonic symptoms. Alternatively, if different
results emerge for larger samples, different time windows, or particular subgroups (e.g.,
certain age or diagnostic groups), that information would provide important guidance for
preclinical models of stress-induced anhedonia, and might inform the development of
new predictive tools and clinical interventions.
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Chapter 4: Frontostriatal Connectivity as a
Possible Mediator of Stress-Induced
Anhedonia
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Abstract
Anhedonia (loss of pleasure/lack of motivation) is a debilitating condition that
cuts across diagnostic categories, yet little is known about the biological etiology of
stress-induced anhedonia. We hypothesized that frontostriatal functional connectivity
would statistically mediate the stress-anhedonia link in a sample of older adults (ages 4069) from the UK Biobank database, split into discovery (n = 6,144) and replication (n =
4,101) samples. Bootstrapped regression analyses indicated that self-reported financial
stress over the past 2 years was associated with self-reported anhedonia across both the
discovery (B = .22; SE = .04; 95% CI: [.14, .31]) and replication (B = .25; SE = .05; 95%
CI: [.16, .35]) samples. Additionally, number of stressors endorsed significantly predicted
anhedonia score across the discovery (B = .06; SE = .01; 95% CI: [.06, .08]) and
replication (B = .06; SE = .01; 95% CI: [.04, .09]) samples. Next, functional parcellation
of cortex facilitated the identification of medial prefrontal cortex (mPFC) parcels with the
highest functional connectivity to anatomically-defined nucleus accumbens (NAc).
However, bootstrapped mediation models found no evidence that frontostriatal functional
connectivity mediated the stress-anhedonia association, either for financial stress or
number of stressors endorsed. Additionally, associations between frontostriatal
connectivity and anhedonia scores were unstable across the discovery and replication
samples, suggesting no reliable relation between frontostriatal connectivity and
anhedonia. These null findings may have resulted from incorrect hypotheses, unreliable
measurements, or insufficiently detailed measurement of psychological stress exposure.
Large samples with more detailed psychiatric phenotyping alongside key biological
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measures are sorely needed to advance understanding of the etiology of anhedonia, as
well as the effects of stress on human psychiatric functioning more broadly.
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Introduction
Anhedonia, the loss of pleasure and/or motivation observed in several types of
psychiatric problems (Husain & Roiser, 2018), presents a debilitating emotional burden
and is associated with increased suicide risk in individuals with mental illness (Fawcett et
al., 1990). Cross-species work suggests that psychological stress leads to decreased
motivated behavior in animals (Hollon et al., 2015; Russo & Nestler, 2013) and is
associated with anhedonic symptoms in humans (Keller et al., 2007). Although the
biological mechanism through which stress may influence anhedonia remains unclear,
substantial work suggests that stress-induced alterations in frontostriatal functioning—
particularly interactions between medial prefrontal cortex (mPFC) and mesolimbic
circuitry—could impact motivated behavior, possibly contributing to anhedonia (Russo &
Nestler, 2013). However, few studies have assessed whether frontostriatal interactions
statistically mediate the effects of stress on anhedonia in humans.
Notably, stress causes wide-ranging changes in brain structure and function,
including in hippocampus, amygdala, and across prefrontal cortex (Arnsten, 2009;
McEwen et al., 2015). These interconnected regions, which are not limited to
frontostriatal circuitry, may all contribute to stress-induced anhedonia, given their roles in
fear conditioning and responding (LeDoux, 2000; Milad & Quirk, 2002; Phelps et al.,
2004) and guiding behavior based on incentive value (Kable & Glimcher, 2007; Murray,
2007; Rangel & Hare, 2010). However, given promising work on mPFC-mesolimbic
dynamics and motivated behavior that spans rodents (Ferenczi et al., 2016; Moreines et
al., 2017) and humans (Admon & Pizzagalli, 2015; Drysdale et al., 2017), the present
study focuses on the role of frontostriatal functioning.
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Nonhuman animal models suggest that stress could alter motivated behavior,
which is thought to be an important contributor to anhedonia (Pizzagalli, 2014; Zald &
Treadway, 2017), through structural and functional changes in mPFC-mesolimbic
circuitry. Stress exposure in rodents leads to well-documented structural alterations in
mPFC, including dendritic shrinking and spine loss (McEwen & Morrison, 2013).
Additionally, rodent work suggests that optogenetic manipulations to mPFC excitability
can decrease motivated behavior and diminish blood oxygenation level-dependent
(BOLD) striatal responses to midbrain dopaminergic activity (Ferenczi et al., 2016).
Furthermore, in a separate study, chronic mild stress (CMS) in rats decreased the number
of spontaneously firing dopamine neurons in medial and central ventral tegmental area
(VTA; Moreines et al., 2017). Pharmacological inactivation of mPFC using tetrodotoxin
prevented these changes (Moreines et al., 2017), suggesting that mPFC activity may
mediate the impact of stress on dopaminergic midbrain functioning, which plays a key
role in reward responding and motivated behavior (Berridge et al., 2009; Mirenowicz &
Schultz, 1994; Schultz, 2016).
In humans, fMRI studies have found that mPFC-striatal connectivity may
contribute to anhedonia among individuals with MDD and remitted MDD (rMDD). One
study attempted to delineate biological sub-phenotypes (“biotypes”) using BOLD
functional connectivity data and MDD symptoms (Drysdale et al., 2017). Hierarchical
clustering analyses suggested four biotypes determined by similar patterns of
connectivity features. Hyperconnectivity in frontostriatal and thalamic networks
characterized two of the biotypes. Additionally, frontostriatal hyperconnectivity was
linked to anhedonia and psychomotor retardation (Drysdale et al., 2017). These results
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suggest that frontostriatal connectivity, as assessed in humans via fMRI, may be
associated with anhedonia status. This hypothesis is also consistent with findings from
another study of rMDD individuals, in which patterns of frontostriatal functional
connectivity predicted positive emotional responses to a naturalistic mood induction
(Admon & Pizzagalli, 2015).
Despite cross-species work suggesting that frontostriatal interactions are
perturbed by stress and associated with motivated behavior, positive affect, and
anhedonic symptoms, we are aware of no studies that have assessed whether
frontostriatal connectivity mediates the relation between stress and anhedonia in humans.
We propose to address this hypothesis by examining resting-state functional connectivity
(RSFC) between mPFC and ventral striatum (part of the mesolimbic pathway) in a
subsample of the UK Biobank study (Sudlow et al., 2015; see additional details below).
RSFC assesses temporal correlations in BOLD signal oscillations across brain
regions while participants are asked to rest quietly in the scanner. Several studies have
found correspondence between resting-state and task-based activity (Cole, Ito, Bassett, &
Schultz, 2016). As a result, researchers have argued that resting-state and task-based
activity draw on a common functional network architecture (e.g., Cole, Bassett, Power,
Braver, & Petersen, 2014). Thus, examining differences in patterns of resting-state
activity following stress may reveal changes to the brain’s functional architecture that
increase anhedonia risk.
However, some evidence suggests that the direction of the resting-state
correlation between two regions (i.e., positive or negative) may not match the direction of
the task-evoked relation between those same regions. For example, during emotion77

related tasks, stronger inverse ventromedial PFC-amygdala functional connectivity is
associated with lower anxiety (Hare et al., 2008; H. Kim et al., 2004; Urry et al., 2006).
Yet at rest, positive functional connectivity between these regions is linked to lower
anxiety (Burghy et al., 2012; Hahn et al., 2011; M. J. Kim, Gee, Loucks, Davis, &
Whalen, 2011). In this case, the same phenotype is associated with inverse functional
connectivity between two regions during a relevant task, but positive RSFC between the
same two regions at rest. Increased, positive mPFC-striatal functional connectivity has
been observed in rodents that exhibited heightened mPFC excitability and decreased
motivated behavior (Ferenczi et al., 2016) as well as in humans with anhedonia (Drysdale
et al., 2017). Thus, we predicted that the same pattern would hold in the present study,
such that anhedonia would be associated with positive frontostriatal RSFC. We also
hypothesized that changes in frontostriatal connectivity would mediate the association
between stress and anhedonia.
As an exploratory follow-up, we investigated whether frontostriatal RSFC might
mediate the stress-anhedonia relation for some subgroups of individuals. Some work
suggests that frontostriatal reward processing changes with age, such that midbrain
dopaminergic processing is less associated with prefrontal reward-related activity in older
adults (Dreher, Meyer-Lindenberg, Kohn, & Berman, 2008) and older adults exhibit a
decreased tendency to shift striatal BOLD activity from reward receipt to reward
anticipation (Vink, Kleerekooper, van den Wildenberg, & Kahn, 2015). Additionally, sex
differences in rates of MDD are well-documented (Kessler et al., 2003), and anhedonia is
a primary symptom of MDD (American Psychiatric Association, 2013), leaving open the
possibility that the mechanism of stress-induced anhedonia could vary based on sex
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assigned at birth. Thus, we will examine whether frontostriatal connectivity might
mediate the link between stress and anhedonia differently for younger vs. older
individuals, and for individuals assigned female at birth vs. assigned male at birth.
Methods
Participants
UK Biobank is a cohort study of more than 500,000 individuals from the United
Kingdom, recruited to participate at one of 22 sites across the UK (Sudlow et al., 2015).
Participants were aged 40-69 when recruited between 2006-2010, and completed a wide
variety of measures, including blood, urine, and saliva samples, physical measurements,
and self-report questionnaires. In 2014, UK Biobank invited 100,000 of the original
participants to participate in brain magnetic resonance imaging (MRI), including restingstate functional MRI, which can be used to investigate RSFC. At the time this analysis
was conducted, scans from 10,472 individuals had been preprocessed using a pipeline
developed by collaborators (see below).
MRI Data Acquisition and Preprocessing
Functional MRI acquisition. As part of the UK Biobank study, participants
completed T1-weighted, T2-FLAIR, susceptibility-weighted (swMRI), and diffusionweighted MRI (dMRI). A detailed summary of the UK Biobank brain imaging protocols
are available elsewhere (K. L. Miller et al., 2016). Briefly, resting-state functional MRI
data were collected at three dedicated imaging centers, each using a 3T Siemens Skyra
(software platform VD13) with the standard Siemens 32-channel head coil. Acquisition
parameters were as follows: 2.4-mm spatial resolution, 88 x 88 x 64 field-of-view matrix,
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TR = 0.735 s, TE = 39 ms, flip angle = 52°, GE-EPI with 8x multiband acceleration, fat
saturation. To facilitate motion correction and alignment, a single-band reference image
with higher tissue-type image contrast was acquired. During the 6 min 10 s resting-state
scan, participants were instructed to keep their eyes fixated on a crosshair, relax, and
“think of nothing in particular” (K. L. Miller et al., 2016).
Preprocessing of structural and functional MRI data. Structural and functional
MRI data were preprocessed through a collaboration with the Holmes Laboratory at Yale
University. Structural MRI data from 10,472 UK Biobank participants were processed
via a structural MRI pipeline using FreeSurfer version 6.0 (Fischl, 2012). Because
evidence suggests that the use of face-stripped anatomicals may lead to shifts in
FreeSurfer-based estimates of cortical anatomy (A. J. Holmes et al., 2015), the present
pipeline applied a modified version of UK Biobank structural preprocessing
(https://git.fmrib.ox.ac.uk/falmagro/UK_biobank_pipeline_v_1) to provide anatomical
images without face blurring for segmentation in FreeSurfer. Anatomical data underwent
gradient distortion correction, reduction of the anatomical image field of view, and joint
linear and non-linear registration to a UK Biobank custom 1mm MNI152 “nonlinear 6th
generation” group atlas. To reduce interpolation error and image distortions, linear and
non-linear transforms to standard space were performed in a single combined
transformation.
To extract RSFC data from cortical regions, surface-based preprocessing was
conducted according to a previously published pipeline
(https://github.com/ThomasYeoLab/CBIG) (Kong et al., 2019; Li et al., 2019). Echoplanar imaging (EPI) frames with frame-wise head-motion greater than 0.3mm or
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DVARS greater than 75 were identified as outliers. These frames, along with one frame
before and two frames after a detected movement, were considered censored data and
later interpolated (see below). FreeSurfer’s boundary-based registration software was
used to align processed structural data with functional images, and a high-contrast EPI
volume provided a functional reference. Additionally, BOLD run segments consisting of
fewer than 5 contiguous frames were flagged for removal. Runs where more than 50% of
frames were outliers were excluded from further analysis. Variance related to global
signal, average white matter signal, average CSF signal, average ventricular signal, six
head motion estimates (3 rotational, 3 translational), and all corresponding temporal
derivatives were removed via linear regression. Censored frames were excluded from this
nuisance regression step, and then interpolated using least-squares spectral estimation.
The resulting data were bandpass filtered (0.009 Hz ≤ f ≥ 0.08 Hz) and linear trends were
removed. Next, the preprocessed volumetric data were projected onto fsaverage6 surface
space, smoothed with a 2mm full-width half-maximum kernel, and downsampled into
fsaverage5 vertex space.
To generate estimates of resting-state functional activity from cortical data, the
same procedure was conducted on non-bandpassed volumetric data. HCP Workbench
(Marcus et al., 2011) was applied to generate parcellated surface-based estimates of
resting-state functional activity (standard deviation of BOLD time course) and functional
connectivity. Resting-state functional activity values were Z-transformed within
individuals, and each participant’s 200x200 matrix of RSFC estimates was Fisher’s Z
transformed.
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To examine resting-state activity in nucleus accumbens, the preprocessing
procedures described above were applied to resting-state functional activity estimates
from nucleus accumbens. Volumetric delineations for bilateral nucleus accumbens were
derived from FreeSurfer’s subcortical segmentation procedure
(https://surfer.nmr.mgh.harvard.edu/fswiki/FsTutorial/AnatomicalROI).
Additional fMRI data reduction. Individuals with missing thickness or restingstate estimates across all 200 cortical parcels, or with average cortical thickness or RSFA
more than ±3 SD from the mean, were excluded from further analysis. Individuals with
outlier (±3 SD) white matter lesion volume were censored from further analyses.
Additionally, participants were excluded for inverted T1-weighted signal-to-noise
ratio > 3 SD above the mean (n = 131) or white matter lesion volumes (residualized for
total gray and white matter volume) > 3 SD above the mean (n = 218). Of the remaining
participants, individuals were excluded for mean run-wise frame-to-frame head motion
during resting-state functional MRI > 3 SD above the mean (n = 51) and inverted restingstate signal-to-noise ratio > 3 SD above the mean. Participants were also excluded if their
data could not be processed through FreeSurfer (n = 30).
Brain Parcellation and Regions of Interest
We adopted a cortical parcellation method that relies on a gradient-weighted
Markov Random Field (gwMRF) model (Schaefer et al., 2017). This particular model
integrates a global similarity approach (which groups brain locations according to
similarity in functional MRI time course) with a local gradient approach (which detects
RSFC patterns that change abruptly from one location to a nearby location). The model
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also includes a spatial distribution term that encourages locations within a parcel to
remain close to the parcel center (Schaefer et al., 2017).
In the present study, to minimize signal dropout and increase signal-to-noise ratio,
we examined functional activity in NAc (part of VS) using an anatomical mask rather
than using a functional parcellation of striatum. We identified mPFC regions of interest
based on a) guidance from prior work and b) statistical strength of correlations with NAc
within the present dataset. Specifically, prior studies have indicated mPFC regions with
particularly strong correlations to VS in terms of both functional connectivity (Choi, Yeo,
& Buckner, 2012) and gene co-expression (Anderson et al., 2018).

Figure 1. VS functional connectivity and gene co-expression in mPFC. (A) Analyses
from Choi et al. (2012) revealed functional connectivity with VS in a region of mPFC
that extends to perigenual cortex (indicated by an arrow). Figure part A adapted from
Choi et al. (2012). (B) Anderson et al. (2018) found overlap between VS functional
connectivity and gene co-expression in perigenual mPFC (indicated by arrows), among
other areas. Figure part B adapted from Anderson et al. (2018).
Additionally, in the present dataset, we identified 13 mPFC parcels whose
functional connectivity estimates with NAc were greater than 2 SD above the mean for
all cortical parcels (Table 1). Estimates of functional connectivity with mPFC were
similar between left and right NAc (Figure 2). Thus, we used the bilateral average of
NAc functional activity to derive mPFC-NAc RSFC estimates, with the goal of
increasing NAc signal reliability.
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Figure 2. Functional correlations with medial cortical parcels are similar between left (A)
and right (B) nucleus accumbens.
Self-Report Questionnaire
During the imaging visit, participants completed a battery of self-report
assessments touching on a wide range of topics, including diet, physical activity,
sociodemographics, and mental health. The full questionnaire is accessible on the UK
Biobank website (https://www.ukbiobank.ac.uk/). To assess life stress, we examined
participants’ self-report regarding whether they had experienced any of the following in
the past 2 years: a) “Serious illness, injury or assault to yourself”; b) “Serious illness,
injury or assault of a close relative”; c) “Death of a close relative”; d) “Death of a spouse
or partner”; e) “Marital separation/divorce”; f) “Financial difficulties”; g) “None of the
above”. Participants were allowed to choose more than one answer for this item.
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Participants who responded “Prefer not to answer” (n = 16) were excluded from analyses.
As a measure of anhedonia, we investigated participant responses to the following
question: “Over the past two weeks, how often have you had little interest or pleasure in
doing things?” Responses were scored as follows: “Not at all” = 0; “Several days” = 1;
“More than half the days” = 2; “Nearly every day” = 3. Participants were allowed to
select only one option for the anhedonia item (UK Biobank, 2018). Individuals who
selected “Do not know” (n = 169) or “Prefer not to answer” (n = 16) for the anhedonia
item were excluded from analyses. Additionally, participants with missing data on
household income (n = 12), which was used as a control variable (see Statistical
Procedures), were excluded from analysis.
Discovery and Replication Samples
To safeguard against the over-interpretation of spurious effects, we split the UK
Biobank imaging dataset into separate discovery and replication samples. To avoid
demographically-skewed samples that might result from simple random sampling, we
applied spatially balanced sampling techniques (M. M. Dickson, Benedetti, Giuliani, &
Espa, 2014) using the BalancedSampling package for R (Grafström & Lisic, 2020).
Subsamples were balanced according to the following dimensions: sex; handedness; age;
household income; head motion; number of self-reported episodes of depressed mood
and number of self-reported episodes of disinterest/lack of pleasure (to control for
chronicity of mood and anhedonic symptoms); and fluid intelligence (to control for
cognitive function; see Bakrania et al., 2018 for more details on cognitive assessment).
The discovery sample consisted of 60% of the overall sample after data cleaning (n =
6,124), and the replication sample comprised the remaining data (n = 4,097).
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Statistical Procedures
All analyses controlled for the following variables, included as covariates: sex;
age; household income; number of self-reported episodes of depressed mood; number of
self-reported episodes of disinterest/lack of pleasure; and fluid intelligence (as a measure
of cognitive function). Additionally, all analyses involving imaging data controlled for
handedness and head motion.
We first investigated whether frontostriatal RSFC (i.e., between mPFC and VS)
was statistically related to anhedonia score in any of the mPFC parcels of interest.
Because anhedonia scores were strongly skewed in favor of lower anhedonia severity
(see Descriptive Statistics), and thus violated assumptions of normality, we adopted a
bootstrapped linear regression approach using the boot package for R (Canty & Ripley,
2020). A series of bootstrapped regressions was conducted, each one using frontostriatal
RSFC Z-score from a different mPFC parcel of interest as the predictor and anhedonia
score as the criterion, yielding a total of 13 bootstrapped regressions (one for each mPFC
parcel of interest). For each regression, coefficients were obtained within each of 10,000
bootstrapped samples, and BCa bootstrap confidence intervals (DiCiccio & Efron, 1996)
were constructed for each coefficient. RSFC was considered to have a significant effect
on anhedonia score for a parcel in mPFC if the bootstrap confidence interval for its
regression coefficient did not contain zero.
Next, we characterized the relation between stress and anhedonia. We conducted
a bootstrapped linear regression using dummy coded variables for each type of stressor (0
= absent, 1 = present) as the predictors and anhedonia score as the criterion. Additionally,
in separate analyses, we examined whether the number of stressors endorsed by a
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participant predicted anhedonia score. The procedure described above was used to
generate bootstrapped samples and confidence intervals, as well as to evaluate statistical
significance.
In addition, we applied bootstrapped mediation techniques (Preacher & Hayes,
2004) using the mediation package for R (Tingley, Yamamoto, Hirose, Keele, & Imai,
2014) to examine whether frontostriatal connectivity could plausibly mediate the relation
between stress and anhedonia score. We constructed mediation models as follows: a) the
predictor in each model was a stressor that significantly predicted anhedonia score; b) the
putative mediator in each model was the frontostriatal connectivity Z score from an
mPFC parcel whose connectivity score significantly predicted anhedonia score; c) the
outcome variable was anhedonia score. Models were estimated for all combinations of
significantly-predictive stressors and significantly-predictive frontostriatal connectivity
estimates. In separate models, we also evaluated whether frontostriatal connectivity
mediated the relation between number of stressors endorsed and anhedonia score.
Mediation by frontostriatal connectivity was considered statistically significant if the
95% bootstrap confidence interval for the proportion mediated, or c – c’ (Preacher &
Hayes, 2004), did not contain zero.
Finally, on an exploratory basis, we constructed moderated mediation models. We
investigated whether frontostriatal connectivity might mediate the stress-anhedonia
relation for subgroups of participants based on age or sex assigned at birth. To do so, we
split the sample and applied mediation analyses to each subsample. For sex assigned at
birth, we split the sample into female vs. male assigned at birth, and fit mediation models
to each of those subsamples. For age, we used a median split to create two subsamples
87

and fit mediation models to each. Again, we assessed whether the 95% bootstrap
confidence interval of c – c’ contained zero for each subsample.
Once all analyses were finalized in the discovery sample, we conducted the same
statistical procedure in the replication sample to assess reliability of results.
Results
Descriptive Statistics
Tables 1, 2, and 3 present descriptive statistics for the overall sample (discovery
and replication samples together). Table 1 includes the number of individuals who
endorsed each response on the anhedonia item, as well as the number of individuals who
endorsed each type of stressor over the 2 years prior to the imaging visit. Table 2
provides descriptive statistics for continuous demographic variables. Descriptive statistics
for categorical demographic variables are listed in Table 3.
Participants endorsed 0.48 stressors per person on average (SD = 0.69).
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Table 1. Descriptive statistics for self-reported stressors and anhedonia
n Participants
Endorsing Item

Percentage of Overall
Sample

Serious illness, injury or assault
to yourself

603

5.9%

Serious illness, injury or assault
of a close relative

1,291

12.6%

Death of a close relative

2,132

20.9%

Death of a spouse or partner

134

1.3%

Marital separation/divorce

171

1.7%

Financial difficulties

579

5.6%

6,302

61.7%

Not at all

8,602

84.2%

Several days

1,355

13.3%

163

1.6%

Self-Report Item
Stressors endorsed (past 2 years)

None of the above
Anhedonia (past 2 weeks)

More than half the days

Nearly every day
97
0.9%
Note. Participants were allowed to endorse as many stressors as applied to them.

Table 2. Descriptive statistics for continuous demographic variables
Self-Report Item
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M

SD

Age at imaging visit

62.66

7.39

Lifetime number of depressive episodes

1.60

13.74

Lifetime number of anhedonic episodes

1.06

6.37

Fluid intelligence score

6.08

2.95

Table 3. Descriptive statistics for categorical demographic variables
n Participants Endorsing
Item

Percentage of Overall
Sample

Female

5,384

52.7%

Male

4,833

47.3%

Right-handed

9,099

89.1%

Left-handed

968

9.5%

Use both right and
left hands equally

148

1.5%

Less than £18,000

1,177

11.5%

£18,000 to £30,999

2,634

25.8%

£31,000 to £51,999

2,861

28.0%

£52,000 to £100,000

2,068

20.2%

Greater than £100,000

540

5.3%

Prefer not to answer

637

6.2%

Do not know

300

2.9%

Self-Report Item
Sex assigned at birth

Handedness

Annual household income

Relation between Frontostriatal Connectivity and Anhedonia
Discovery sample. The mPFC-NAc connectivity Z-scores of two mPFC parcels
significantly predicted anhedonia score: LH_Limbic_OFC_3 (B = -.05; SE = .02; 95%
CI: [-.10, -.01]) and LH_Default_PFC_4 (B = -.06; SE = .03; 95% CI: [-.11, -.01]).
Contrary to our hypotheses, the estimated slopes for the impact of frontostriatal
connectivity on anhedonia score were both negative, such that more negative
frontostriatal connectivity scores were weakly predictive of higher anhedonia scores.
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Replication sample. Frontostriatal connectivity did not significantly predict
anhedonia score for any of the identified mPFC parcels. This result suggests that, given
the present data and analytic strategy, frontostriatal functional connectivity did not
reliably predict anhedonic symptoms.
Associations between Self-Reported Stress and Anhedonia
Discovery sample. Four stressors emerged as significant predictors of anhedonia
score: a) “Serious illness, injury or assault to yourself” (B = .07; SE = .04; 95% CI: [.01,
.15]); “Serious illness, injury or assault of a close relative” (B = .06; SE = .02; 95% CI:
[.02, .11]); and “Financial difficulties” (B = .22; SE = .04; 95% CI: [.14, .31]).
Additionally, number of stressors endorsed significantly predicted anhedonia score (B =
.06; SE = .01; 95% CI: [.06, .08]).
Replication sample. Only one individual stressor emerged in the replication
sample as a significant predictor of anhedonia score: “Financial difficulties” (B = .25; SE
= .05; 95% CI: [.16, .35]). This outcome suggests that, of stressors endorsed over a 2-year
period prior to assessment, only financial difficulties reliably predicted anhedonia scores.
However, as in the discovery sample, number of stressors significantly predicted
anhedonia score (B = .06; SE = .01; 95% CI: [.04, .09]).
Frontostriatal Connectivity as a Putative Mediator of the Stress-Anhedonia Association
Discovery sample. We examined frontostriatal connectivity in the two mPFC
parcels that exhibited a significant association with anhedonia score in the discovery
sample. In the model testing functional connectivity between the parcel
LH_Limbic_OFC_3 and NAc as a mediator of the relation between financial difficulties
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and anhedonia score, frontostriatal connectivity emerged as a significant mediator (c – c’
= -.01, 95% CI: [-.03, -9.63]). Contrary to our predictions, the estimated value of c – c’
was negative, such that the relation between stress and anhedonia was stronger when
accounting for frontostriatal connectivity. This result is inconsistent with the mediation
hypothesis, which would predict that the relation between stress and anhedonia weakens
when frontostriatal connectivity is taken into account. Results for the other medial
prefrontal parcel of interest (LH_Default_PFC_4) revealed no significant mediation (95%
confidence interval for c - c’ contained zero). When examining frontostriatal connectivity
as a mediator of the relation between number of stressors endorsed and anhedonia, no
evidence for mediation emerged (95% confidence interval for c – c’ contained zero).
Replication sample. Because frontostriatal connectivity did not significantly
predict anhedonia score for any mPFC parcels in the replication sample, no mediation
models were tested in the replication sample. Thus, the results of the significant
mediation model from the discovery sample cannot be confirmed, and cannot be
considered reliable. Additionally, because frontostriatal connectivity did not significantly
mediate the relation between number of stressors endorsed and anhedonia in the
discovery sample, we did not evaluate this model in the replication sample.
Moderated Mediation
Discovery sample. We tested moderated mediation models for each parcel that
was significantly associated with anhedonia scores (see Frontostriatal connectivity
Predicting Anhedonia Score, above). For models testing whether frontostriatal
connectivity mediated the stress-anhedonia relation in participants in the younger half of
the sample (ages 45-63) and the older half of the sample (ages 64-80) separately, all 95%
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confidence intervals for c – c’ contained zero, providing no evidence of mediation. The
same pattern emerged for testing mediation in assigned female at birth and assigned male
at birth participants separately, such that 95% confidence intervals for c – c’ all contained
zero. Thus, we uncovered no evidence that frontostriatal connectivity mediates the stressanhedonia relation for subgroups of individuals.
Discussion
This study provided no evidence to support the hypothesis that stress impacts
anhedonic symptoms via changes in frontostriatal functioning. In our sample, one stressor
type (“financial difficulties”) was related to anhedonic symptoms, consistent with the
literature on stress-induced anhedonia. However, frontostriatal RSFC was not
consistently associated with anhedonic symptoms in any of the medial prefrontal parcels
assessed. Furthermore, our analysis does not support frontostriatal RSFC as a statistical
mediator of the stress-anhedonia association, either for the overall sample or for
subgroups of individuals (i.e., younger vs. older individuals, assigned female vs. male at
birth).
Several explanations could plausibly account for these null results. First,
frontostriatal function may not act as a mechanism of stress-induced anhedonia. Although
stress leads to structural changes in mPFC (McEwen & Morrison, 2013), these alterations
may not contribute to anhedonia, or may influence anhedonic symptoms through other
mechanisms besides altered frontostriatal functioning.
Additionally, data for the present study were collected as part of a larger
investigation (the UK Biobank study) that was not specifically designed to assess the
impact of stress and brain function on anhedonic symptoms. As a result, stress exposure
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and anhedonic symptoms were minimally assessed, and may not provide the reliability
and/or validity of standardized stress measures. For instance, some researchers have
argued that the Life Events and Difficulties Schedule (LEDS; Bifulco et al., 1989) should
be the gold standard for measuring the impact of stress exposure on psychopathology
(Harkness & Monroe, 2016), due to its assessment of a large number of stressors and
examination of key stress characteristics, such as timing, chronicity, and severity. This
study also did not include an anhedonia measure with established reliability and/or
validity, such as the Mood and Anxiety Symptoms Questionnaire (MASQ) Anhedonic
Depression subscale (Watson, Weber, et al., 1995). Thus, the measures of stress and
anhedonia included in this study may be insufficient to address the study’s key questions.
Notably, the UK Biobank dataset provides a freely-available, large sample with diverse
measures, which rendered the present study feasible. At the same time, the brevity of the
symptom inventories included (which facilitated their administration to thousands of
participants) represented a significant methodological barrier to the present investigation
of stress and anhedonia.
Moreover, the stress questionnaire used in the present study inquired about 6
stressful events over a 2-year period prior to assessment. Inquiring about a 2-year period
may provide insufficient temporal resolution to identify stressors of maximal etiological
importance to anhedonia. Prior work in individuals with MDD suggests that events
within 6 months prior to MDD onset are of greatest etiological relevance to MDD
(Harkness et al., 2010; Kendler et al., 1998). Furthermore, a more comprehensive inquiry
about stress exposure might take into account stressors that are neglected in the present
assessment. For example, researchers have suggested that targeted rejection events
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particularly contribute to depressive symptoms (Slavich, Thornton, Torres, Monroe, &
Gotlib, 2009), and these may be incompletely assessed using the 6 questionnaire items
from the UK Biobank dataset.
Analyses suggested that self-reported financial stress over the past 2 years reliably
predicted self-reported anhedonia severity, even after controlling for a number of
demographic variables, depression/anhedonia chronicity, and several other stressors.
Additionally, number of stressors endorsed also predicted anhedonia. These findings are
consistent with other work that indicates a link between stress and anhedonia in humans
(e.g., Keller et al., 2007). Although financial stress emerged as a predictor of anhedonia
above and beyond the other stressors assessed, we caution against placing particular
emphasis on financial stress as a contributor to anhedonia, for several reasons. First, only
a small number of stressors were assessed, leaving open the possibility that other
stressors could have stronger links with anhedonia. Additionally, as noted above, the 2year time window for stressors assessed was quite broad, and as a result our analysis may
not have detected the effects of stressors that exert greater influence over a more
constrained time window. Finally, the present data did not allow for us to examine the
impact of key dimensions of stress (e.g., chronicity, severity) which may better account
for any pattern in stressors that contribute strongly to anhedonic symptoms.
Overall, this study did not uncover evidence that frontostriatal function mediates
the effect of stress on anhedonia. At the same time, the null results of the present study
cannot not rule out this hypothesis. Future work could better address this problem
through the use of large datasets that include more detailed stress and symptom
inventories, while also incorporating measures of putative biological mediators, such as
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functional connectivity. Despite the practical challenges involved in collecting such a
dataset, these efforts could be essential to understanding the impact of stress on
psychiatric symptoms and accompanying biological mechanisms.
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Chapter 5: Inflammation as a Potential
Mediator of Stress-Induced Changes in
Motivated Behavior
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Abstract
Prior work suggests that stress exposure is linked with anhedonia, the loss of
pleasure and/or motivation, a debilitating psychiatric condition (Pizzagalli, 2014; Russo
& Nestler, 2013). Emerging research suggests that immune responses to stress may
mediate this stress-anhedonia link through the regulation of inflammatory cytokine
activity (Felger & Treadway, 2017). However, human subjects work has produced mixed
results (Boyle et al., 2020; Treadway et al., 2017) that require clarification. The present
study applied a well-validated psychosocial stressor (Kirschbaum, Pirke, & Hellhammer,
1993a) or corresponding control task, and investigated potential changes in inflammatory
cytokine concentration and reward- and loss-based learning. Relative to the control
group, the stressor produced a significant increase in negative affect (ATS = 15.18, df =
2.61, p < .001), suggesting a successful stress manipulation. Nevertheless, unexpectedly,
no differences emerged in salivary concentration of pro-inflammatory cytokines. These
results are inconsistent with the findings of meta-analyses of studies using human blood
serum (Marsland, Walsh, Lockwood, & John-Henderson, 2017) and saliva (Szabo,
Slavish, & Graham-Engeland, 2020). Low concentrations of some pro-inflammatory
cytokines (< 1 pg/mL for IL-6, e.g.) suggest problems with sample storage, which may
account for these null results. Additionally, no significant effects of stress on reward- or
loss-based learning emerged, consistent with some prior work that found no effect of
stress on behavior using similar tasks (Treadway et al., 2017). Altogether, this study
provided no evidence for mediation of the stress-anhedonia link by inflammatory
processes in humans, possibly due to methodological constraints or the absence of a true
effect.
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Introduction
Several debilitating psychiatric disorders, including major depressive disorder
(MDD), schizophrenia, and post-traumatic stress disorder (PTSD), are linked to stress
and characterized by anhedonia, defined as the loss of pleasure and/or motivation to
engage in valued activities (Barch & Dowd, 2010; Nawijn et al., 2015; Pizzagalli, 2014).
These disorders cause a significant personal, societal, and economic burden worldwide
(Whiteford et al., 2013). However, the biological pathways linking stress and anhedonia
remain poorly understood. The present study aims to address this critical issue by
examining inflammatory processes as a potential biological mediator of the stressanhedonia link.
Considerable work has focused on inflammatory responses to stress and
subsequent effects on motivated behavior—an important component of anhedonia
(Treadway & Zald, 2011)—and the impact of stress on relevant neural circuitry (Felger &
Treadway, 2017). Preclinical models suggest that pro-inflammatory cytokines, such as
interleukin-6 (IL-6), may contribute to stress-induced anhedonia (Hodes et al., 2014;
Menard et al., 2017; J. Wang et al., 2018). For instance, social defeat stress in rodents
appears to weaken the blood-brain barrier by reducing levels of Cldn5, a cell adhesion
molecule, allowing IL-6 to infiltrate nucleus accumbens (NAc) and producing diminished
social interaction (Menard et al., 2017). Stress-induced IL-6 infiltration, in conjunction
with synaptic remodeling in NAc (J. Wang et al., 2018), appears to contribute to the
development of anhedonic-like behavior (Hodes et al., 2014; Menard et al., 2017; J.
Wang et al., 2018).
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In humans, a study of healthy female participants examined the effect of stressinduced inflammation on reward prediction errors (RPEs) in ventral striatum (VS;
includes NAc) using fMRI (Treadway et al., 2017). Stress-induced increases in IL-6
were associated with diminished RPE-linked responses in VS following stress (Treadway
et al., 2017). Additionally, a recent study of healthy young women found that stressinduced increases in IL-6 mediated the impact of stress on changes in reward
responsiveness (Boyle et al., 2020). However, contrary to the researchers’ expectations,
results indicated that stress-induced IL-6 was associated with increased responsiveness
(Boyle et al., 2020). Given the importance of evaluating stress-induced inflammation as a
biological mechanism of stress-induced anhedonia, these surprising results call for
verification in an independent sample.
In summary, while work in rodents has established a plausible biological pathway
through which stress could produce anhedonic behavior through inflammatory activity
(Hodes et al., 2014; Menard et al., 2017; J. Wang et al., 2018), human work has been
mixed, with at least one study finding an increase in behavioral reward sensitivity (Boyle
et al., 2020), whereas another study found changes in NAc activity but no behavioral
differences (Treadway et al., 2017). These conflicting behavioral results following stressinduced inflammation are consistent with mixed results using other inflammatory
inductions, such as vaccination, which has produced reports of blunted (Harrison et al.,
2016) or enhanced (Boyle et al., 2019) reward learning.
The present study aims to clarify these inconsistent results and evaluate the
impact of stress-induced inflammation on motivated behavior. This study is similar to
prior work that adopted a group-based design (Boyle et al., 2020) with both a stress and
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control group, to mitigate the possible impact of task learning effects when examining
behavior pre- and post-stressor (Treadway et al., 2017). However, we extend prior work
by evaluating both reward-based and loss-based learning (Pessiglione, Seymour, Flandin,
Dolan, & Frith, 2006) within a group design, following evidence that inflammation may
differentially impact learning from rewards versus losses (Harrison et al., 2016). Notably,
although reward learning is thought to be especially relevant to anhedonia, motivated
decision-making is a complex and multifaceted process, and behavioral changes that
culminate in anhedonia could result from disruptions in several different subprocesses
(Zald & Treadway, 2017), including loss-based learning.
We predict that the stress manipulation will increase the salivary concentration of
pro-inflammatory cytokines. Additionally, we expect that because the stressor increases
inflammation, it will decrease reward sensitivity across behavioral tasks, but enhance
sensitivity to losses, consistent with prior work (see Harrison et al., 2016). Finally, we
hypothesize that stress-induced changes in pro-inflammatory activity will mediate the
relation between stress and reward/loss learning. Because of evidence that an individual’s
history of life stress may influence their inflammatory responding to novel stressors
(Fagundes & Way, 2014; Pace et al., 2006), we will also investigate whether these effects
are moderated by life stressor history.
In addition to our main aims, this study provides an opportunity to explore the
impact of stress-induced anti-inflammatory processes on motivated behavior. Some preclinical evidence suggests that anti-inflammatory activity is decreased relative to chronic
stress in rodents (Rossetti et al., 2016), and clinical trials have targeted anti-inflammatory
pathways in treatments for depression (Köhler et al., 2014; Lee et al., 2020). However,
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we are aware of no studies that examine anti-inflammatory responses following stress and
their association with motivated behavior. Therefore, we will perform exploratory
analyses to a) characterize the anti-inflammatory response to an acute laboratory stressor;
b) examine associations between anti-inflammatory responses and motivated behavior;
and c) investigate anti-inflammatory responses as a possible mediator of the impact of
stress on motivated behavior.
Methods
Participants
The Yale University Institutional Review Board approved all procedures, and
participants received monetary compensation for their time. A total of 88 adult
participants were enrolled in the study after screening procedures, and 86 completed the
experiment. Two participants declined to continue their participation in the study after
learning about the stressor task. Participants were recruited via flyering and Craigslist
advertisements. Participant ages ranged from 18 to 56 (M = 27.37, SD = 9.30 years), and
49.2% of participants identified as white, 23.8% as Black or African American, 17.5% as
Asian or Asian American, 3.2% as Middle Eastern or Arab, and 6.3% as mixed race or
other. Additionally, 12.3% of participants identified as Hispanic or Latinx.
Given sex differences in inflammatory and hormonal responses to stress
(Kirschbaum, Wüst, & Hellhammer, 1992; O’Connor et al., 2009; Welsh, Woodward,
Rumley, & Lowe, 2008), and consistent with prior work (Treadway et al., 2017), the
participant sample was restricted to individuals assigned female at birth. Menstrual cycle
stage impacts inflammatory cytokine concentrations (O’Connor et al., 2009), and
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restricting the sample by birth sex enables statistical control for this important contributor
to inflammatory processes.
Additionally, due to potential influence on inflammatory markers (O’Connor et
al., 2009), participants were excluded for nicotine use in the past month; use of selective
serotonin reuptake inhibitors (SSRIs), statins, or antihypertensive medications in the past
6 months; or self-reported inflammatory disease (e.g., rheumatoid arthritis, diabetes
mellitus). Because inflammatory markers were assessed in saliva, individuals with selfreported periodontal health problems, such as gingivitis (see Slavish, Graham-Engeland,
Smyth, & Engeland, 2015), were also excluded from the study.
Stress and Control Tasks
Modified Trier Social Stress Test (TSST). Participants who were randomized to
the stress condition underwent a modified version of the Trier Social Stress Test (TSST),
a well-validated laboratory stress induction designed to induce social-evaluative threat
(Kirschbaum, Pirke, & Hellhammer, 1993b). Prior work suggests that the TSST reliably
elicits subjective and physiological stress responses (Dickerson & Kemeny, 2004;
Kirschbaum et al., 1993b), including inflammatory responses (Izawa et al., 2013; Slavich,
Way, Eisenberger, & Taylor, 2010). Like in other variations of the TSST (Yoon &
Joormann, 2012), the stress induction involved one speech and one arithmetic task. The
stressor tasks were performed in front of an experimenter wearing a lab coat and carrying
a clipboard, who maintained a cold, flat demeanor throughout the stressor. For
consistency, the same male experimenter conducted the TSST or control tasks for all
participants. In the stressor tasks, participants were told that both tasks assessed aspects
of intelligence, and that a panel of their peers would rate their videotaped performance.
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Participants were asked to spend 3 min preparing a speech on why they were “an ideal
job candidate,” and then give a 5-min speech while standing in front of the experimenter
and a video camera. Unbeknownst to participants, they were not actually recorded. Next,
participants were asked to count backwards from 2083 to zero in increments of 17, out
loud. Each time a mistake was made, the experimenter responded “incorrect,” and
instructed the participant to restart from the beginning. Participants engaged in this
arithmetic task for 5 min.
Non-evaluative control tasks. By contrast, participants in the control condition
engaged in tasks designed to approximate the physical demands of the TSST, but without
the social evaluative threat (Het, Rohleder, Schoofs, Kirschbaum, & Wolf, 2009).
Participants spent 3 min thinking about a movie, novel, or recent trip that was relatively
neutral in terms of affective content, and then stood up and talk about the chosen topic for
5 min while alone in the room. Next, participants spent 5 min counting up from zero in
increments of 15. Participants were explicitly told they were not being recorded and that
no one would be able to hear them complete the tasks.
Self-Report Measures
Positive and Negative Affect Scales – Short Form (PANAS-SF). The PANASSF (Watson, Clark, & Tellegen, 1988) comprises two widely-used 10-item mood scales
which are internally consistent and stable over a 2-month period. The two subscales
measure positive affect (e.g., “enthusiastic,” “proud,” “determined”) and negative affect
(e.g., “distressed,” “upset,” “afraid,” “angry”), respectively (Watson et al., 1988).
Stress and Adversity Inventory (STRAIN). The STRAIN (Slavich & Epel,
2010; Slavich & Shields, 2018) assesses lifetime exposure to acute and chronic stress.
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The adult version of the STRAIN inquires about 55 different types of stressors that cover
all major life domains (e.g., health, intimate relationships, friendships, education, etc.)
and several social-psychological characteristics (e.g., interpersonal loss, physical danger,
role change, etc.). Users are presented with one question at a time. For each stressor
endorsed, users are asked a series of follow-up questions to assess the severity,
frequency, timing, and duration of the stressor. In prior work, the STRAIN has
demonstrated convergent validity with other inventories of stress exposure and excellent
reliability (Slavich & Shields, 2018).
Biological Measures
Cytokine assays. Inflammatory markers were measured using saliva samples.
Following collection, samples were stored in a -80ºC freezer until they could be sent for
multiplex assaying (Milliplex high-sensitivity immuno-assays; MilliporeSigma). The
immune multiplex assessed 11 cytokines: interleukin-1β (IL-1β), interleukin-2 (IL-2),
interleukin-4 (IL-4), interleukin-5 (IL-5), interleukin-6 (IL-6), interleukin-8 (IL-8),
interleukin-10 (IL-10), interleukin-12 (IL-12), interleukin-13 (IL-13), tumor necrosis
factor-α (TNF-α), and interferon-γ (IFN-γ). Cytokines with > 20% of data outside the
lower and upper thresholds of detection were excluded from further analysis, leaving six
cytokines: IL-1β, IL-4, IL-6, IL-8, IL-10, and TNF-α. Among these cytokines, IL-1β, IL6, IL-8, and TNF-α are considered broadly pro-inflammatory, while IL-4 and IL-10 are
categorized as anti-inflammatory (Curfs, Meis, & Hoogkamp-Korstanje, 1997), although
the role played by any given cytokine may vary depending on context (Cavaillon, 2001).
Intraclass correlations for these candidate cytokines ranged from .81 for IL-1β to .95 for
IL-10, suggestive of “good” (.75 to .90) to “excellent” (> .90) reliability. Once the
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candidate cytokines were selected, data were cleaned as follows. Subjects with no sample
values within the limits of detection for a particular cytokine were excluded from analysis
for that cytokine. As a result, cytokine data was excluded for certain participants: For
analyses of IL-1β, two participants’ data was excluded; IL-6, nine participants; TNF-α,
seven participants; IL-10, one participant; and IL-4, three participants. For the remaining
data, samples above the upper threshold of detection were treated as missing data, and
samples below the threshold of detection were set to half the lower threshold, consistent
with other longitudinal analyses of inflammatory cytokines (Allswede, Yolken, Buka, &
Cannon, 2020).
Reward Tasks
Pessiglione reward task. A reinforcement learning task designed by Pessiglione
and colleagues (the “Pessiglione task,” for ease of reference; Pessiglione et al., 2006) has
previously been used to examine responses to vaccination-induced inflammation
(Harrison et al., 2016) and psychological stress (Treadway et al., 2017). The task consists
of three blocks of 72 trials each, with each block using three new pairs of abstract
symbols (Figure 1).
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Figure 1. Pessiglione task. Figure adapted from Harrison et al. (2016).
Within each block, each pair of symbols is associated with a different set of
outcomes: in the “gain” condition, either $1 or $0; in the “loss” condition, either -$1 or 0;
in the “no change” condition, either look at gray square or nothing. In the gain condition,
one stimulus is associated with a .8 probability of reward and a .2 probability of nothing
(.8/.2), and the other stimulus has a reversed distribution (.2/.8). The same pattern holds
for the “loss” and “no change” conditions (i.e., one .8/.2 stimulus and one .2/.8 stimulus).
On each trial, one pair of stimuli is presented, with one stimulus on the left and the other
on the right. Left/right position is randomized for each trial. Participants have 4 s to
respond, after which the choice is circled in red for 4 s and the outcome is presented for 4
s (“gain,” “loss,” “nothing,” or “gray square”). In keeping with prior work (Harrison et
al., 2016), we examined participant choices by condition (potential reward vs. potential
loss) in the last 50% of trials in each block. Percentage of high-reward-probability
choices (the “correct” choice in the reward condition) provides a measure of reward
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sensitivity. Conversely, percentage of low-loss-probability choices (the “correct” choice
in the loss condition) provides a measure of punishment sensitivity.
Probabilistic Reward Task (PRT). In the PRT (Pizzagalli et al., 2008;
Pizzagalli, Jahn, & O’Shea, 2005), participants view a mouthless cartoon face on the
screen (Figure 2). After a delay of 500 ms, the “mouth” (a straight line) appears for 100
ms. Participants are required to guess, via key press, whether they have seen the “short”
(11.5 mm) or “long” (13 mm) version of the mouth. The mouths are presented equally
often, in pseudorandom order. No more than three instances of each mouth are presented
consecutively. The present version of this task (Whitton et al., 2015) consists of two
blocks of 100 trials each. On 40 of 100 trials per block, participants receive reward
feedback for 1750 ms following correct responses. Participants earn 20 cents for each
reward.

Figure 2. Signal detection task. The two keys that indicate a guess of “short” or “long”
are counterbalanced, as is which mouth constitutes the “rich” vs. “lean” stimulus. Figure
adapted from Pizzagalli et al. (2005).
Rewards are delivered in an asymmetrical ratio: One mouth type (the “rich” stimulus) is
associated with three times more reward than the other (the “lean” stimulus). This task is
designed to elicit a response bias that increases from the first to the second block. Here,
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response bias (log d) is intended to measure the tendency to choose the disproportionately
rewarded stimulus, quantified by the equation:
1
𝑅𝑖𝑐ℎ𝑐𝑜𝑟𝑟𝑒𝑐𝑡 × 𝐿𝑒𝑎𝑛𝑖𝑛𝑐𝑜𝑟𝑟𝑒𝑐𝑡
𝑙𝑜𝑔𝑑 = 𝑙𝑜𝑔 (
)
2
𝑅𝑖𝑐ℎ𝑖𝑛𝑐𝑜𝑟𝑟𝑒𝑐𝑡 × 𝐿𝑒𝑎𝑛𝑐𝑜𝑟𝑟𝑒𝑐𝑡
where Richcorrect represents the number of correct responses to the rich stimulus, and
Leanincorrect represents the number of incorrect responses to the lean stimulus, etc. Thus,
response bias provides a measure of the tendency to shift responses to favor frequently
rewarded outcomes.
Procedure
Participants were asked to refrain from eating or drinking besides water for an
hour before the study. Consistent with prior work (Treadway et al., 2017), participant
sessions were conducted between 11am-4pm, to control for diurnal variation in
inflammatory markers and cortisol. Following informed consent procedures, participants
completed baseline questionnaires, including affect ratings using the PANAS-SF. Next,
participants provided the first set of saliva samples. Participants were asked to passively
drool through a straw into a vial. At each saliva assessment, participants filled a 1-mL
vial, which were respectively used to assess cortisol (not examined here) and cytokine
concentration.
Participants were then randomly assigned to undergo stress (TSST) or control
tasks. To reduce the possibility that stress/control condition could influence baseline
measures, research staff were blinded to stress/control condition until directly before the
stress/control tasks were conducted. Additionally, participants completed the
stress/control tasks in a different room that was only used for those tasks.
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Following the stress/control tasks, participants completed additional
questionnaires, including the STRAIN. Once 40 minutes had elapsed following the end of
the stress/control tasks, participants completed their second saliva sample and set of
affect ratings. Participants then completed both reward tasks (the Pessiglione task and
the PRT). Finally, participants completed their third saliva sample and set of affect
ratings, after which they were fully debriefed and paid.
Statistical Analysis
Statistical analysis and data visualization were performed using R 3.6.3 (R Core
Team, 2020) supplemented by the tidyverse package ecosystem (Wickham et al., 2019).
In cases where data violated the assumptions of normality and homoscedasticity, we
adopted a nonparametric approach. For categorical variables in a repeated-measures
analysis, we applied the ANOVA-type statistic (ATS; Brunner, Dette, & Munk, 1997), a
rank-based approach that is robust to violations of normality and homoscedasticity.
Unlike other widely used rank-based statistics (e.g., Kruskal, 1952), the ATS
accommodates interaction terms for repeated-measures designs. The ATS is implemented
in the R package GFD (Friedrich, Konietschke, & Pauly, 2017).
However, in some cases, practical limitations prevented the application of the
ATS for non-normally distributed data. In particular, investigations of inflammatory data
typically account for covariates such as analysis plate, menstrual stage, and contraceptive
type. However, using the ATS, it is not presently possible to specify covariates without
adding interaction terms into the model (S. Friedrich, personal communication, March 1,
2021), which in this case would involve estimating dozens of superfluous parameters.
Thus, to examine inflammatory data, we fit linear mixed models (LMMs) using the lme4
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package (Bates, Mächler, Bolker, & Walker, 2015) with nonparametric case
bootstrapping (van der Leeden, Meijer, & Busing, 2008) to estimate 95% confidence
intervals for effects of interest. Bootstrapped LMMs do not require the assumption of
normality or homoscedasticity (van der Leeden et al., 2008), are well-suited to repeatedmeasures designs since they are capable of fitting both fixed and random effects, and can
accommodate covariates. In bootstrapped LMMs, effects were considered statistically
significant if the bootstrap 95% confidence interval for that effect did not contain zero.
Results
Manipulation Check
Self-reported affect. We first examined self-reported affect on the PANAS-SF
negative and positive affect subscales by stress/control condition and time point. Because
subgroups of this data violated assumptions of normality (Shapiro-Wilk p < .05) and
sphericity (Mauchly’s test of sphericity p < .05), the ATS was implemented. As expected,
analyses indicated a significant 3-way interaction of Valence (Negative, Positive) ×
Condition (Stress, Control) × Time (Baseline, Post-stress, Pre-task, Post-task) (ATS =
13.85, df = 2.42, p < .001), and subsequent analysis was conducted to better characterize
this interaction.
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Figure 3. Affect ratings by valence and time.
For negative affect, follow-up analysis revealed a 2-way interaction of Condition
× Time (ATS = 15.18, df = 2.61, p < .001), indicating that the time course of negative
affect significantly differed between the stress and control groups. Figure 3 visualizes the
time course of negative affect in the stress and control conditions. Kruskal-Wallis tests
conducted for each time point found no significant differences between the stress and
control groups at baseline (H = .27, p = .604). However, following the stressor/control
tasks, the stress group reported significantly greater negative affect (H = 22.60, p < .001),
and this difference persisted 40 min later (H = 6.92, p = .009). By the end of the reward
tasks, group differences in negative affect no longer reached the threshold of statistical
significance (H = 3.62, p = .057). As expected, these results suggest that the TSST
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provoked a negative affective reaction relative to the control tasks, which decreased over
the course of the experiment.
For positive affect, the 2-way interaction of Condition × Time was also significant
(ATS = 5.10, df = 2.24, p = .004). The interaction significance appeared to be driven by a
crossover effect between positive affect measured at baseline and following stress/control
tasks (see Figure 3). However, the stress and control groups did not significantly differ on
positive affect at any single time point (p > .05).
Time Course of Inflammatory Markers following Stress
We next examined the impact of the stress manipulation on the time course of
inflammatory markers. Because subgroups of the data violated the assumption of
normality (Shapiro-Wilk p < .05), we applied bootstrapped LMMs to these data.
Pro-inflammatory cytokines. Significant effects of time emerged for two proinflammatory cytokines: IL-1β (β = 0.21, SE = 0.04, 95% CI: [0.12, 0.29]) and IL-8 (β =
0.23, SE = 0.06, 95% CI: [0.12, 0.34]). These results suggest that concentrations of IL-1β
and IL-8 increased with time across the stress/control groups. However, unexpectedly, no
stress/control condition by time effects reached the level of statistical significance for any
pro-inflammatory cytokine (95% CIs contained zero). Thus, we uncovered no evidence
that the stress manipulation modulated pro-inflammatory responding.
Anti-inflammatory cytokines. Analyses indicated a significant effect of time for
IL-10 (β = 0.24, SE = 0.04, 95% CI: [0.15, 0.32]), suggesting that IL-10 increased over
time across all groups. A stress/control condition by time interaction emerged for IL-4 (β
= -0.18, SE = 0.07, 95% CI: [-0.32, -0.03]) and IL-10 (β = -0.16, SE = 0.06, 95% CI: [-
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0.29, -0.03]), suggesting that these anti-inflammatory cytokines decreased following
stress, relative to the control condition. These results are visualized in Figure 4.

Figure 4. Model estimates of anti-inflammatory cytokine concentration, by time and
stress/control condition. Graphs depict model estimates of marginal effects based on
observed parameter values.
Reward- and Loss-Based Learning following Stress
Pessiglione reward task. When examining percentage optimal choice in the
second half of the task (when participants are likely to have learned choice-outcome
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contingencies), Shapiro-Wilk tests indicated that subgroups of the data were nonnormally distributed (p < .05), and subsequent analyses were conducted using the ATS.
The ATS indicated an unanticipated main effect of trial type (reward vs. loss trials; ATS
= 10.63, df = 1, p = .001), such that participants were more likely to respond optimally on
reward trials than on loss trials. Prior reports of results from this task have focused on
group by trial type interaction effects, and to our knowledge, this main effect has not
been publicly reported (Harrison et al., 2016; Pessiglione et al., 2006). Unexpectedly, no
stress/control condition by trial type interaction emerged in our study (p > .05), yielding
no evidence that the stress manipulation differentially influenced reward versus loss
learning in the Pessiglione task.
PRT. Although data cleaning strategies for the PRT are relatively similar across
studies, specific parameters for data removal vary (Boyle et al., 2020; Pizzagalli et al.,
2008, 2005; Whitton et al., 2015). To facilitate comparison, we adopted data cleaning
parameters from a study that also examined the impact of inflammation (Boyle et al.,
2020). Subjects were excluded if they met the following criteria: a) > 80% of trials with
response time < 150 ms or > 2500 ms; b) >= 16 trials more than ±3 SD from the mean; c)
rich/lean reward ratio <= 2.4; d) < 50% accuracy overall. This process removed 10
subjects from the stress group and 10 from the control group, yielding a valid sample of
N = 64. Next, individual trials were rejected if response time was < 150 ms or > 2500 ms,
resulting in the exclusion of 273 out of 12,800 total trials across participants.
Following data reduction, Shapiro-Wilk tests provided no evidence that response
bias was non-normally distributed within stress/control condition and task block (p >
.05), and Levene’s test did not indicate heteroscedasticity (p > .05). Thus, a repeated115

measures ANOVA would be an acceptable choice for this analysis, although the ATS
produces nearly identical results under these conditions. Unexpectedly, neither the
ANOVA nor the ATS revealed any significant effects (p > .05). In the absence of a
Condition (Stress, Control) × Block (1, 2) interaction effect, we accept the null
hypothesis that the stress manipulation did not influence response bias in the PRT as a
measure of reward learning.
Associations with change in negative affect following stress. Because the
stressor may not affect all individuals identically, we conducted bootstrapping
regressions to examine whether change in negative affect following stress predicted
reward/loss learning. Within the stress group, change in negative affect from pre- to poststressor did not significantly predict reward or loss accuracy in the Pessiglione task or
change in response bias from block 1 to block 2 in the PRT (95% confidence intervals
contained zero). These results provide no evidence for altered reward or loss learning,
even in individuals with robust affective responses to the stressor.
Cytokine Activity and Reward/Loss Learning
Analyses indicated that levels of IL-1β, IL-8, and IL-10 increased over time, but
we observed no significant differences in the time course of salivary concentration for
these cytokines based on stress/control condition. On an exploratory basis, we examined
whether changes in concentration of these three cytokines over time (regardless of stress
exposure) were associated with reward/loss learning. We applied bootstrapping
regression models. In each model, change in IL-1β, IL-8, or IL-10 (from baseline to postreward task) served as the predictor variable, and the outcome was either a) reward
accuracy in the second half of the Pessiglione task; b) loss accuracy in the second half of
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the Pessiglione task; or c) response bias in the PRT. Analyses revealed no significant
associations between change in cytokine concentration and reward/loss learning on any
task (95% confidence intervals contained zero).
Additionally, because analyses suggested that the stress manipulation may have
decreased IL-4 concentrations relative to the control condition, we investigated whether
change in IL-4 (from baseline to post-reward task) was associated with reward/loss
learning on the Pessiglione task or PRT. Models were constructed using the same
outcome variables as for IL-1β, IL-8, and IL-10, above. Again, analyses revealed no
significant associations between change in IL-4 concentration and reward/loss learning
(95% confidence intervals contained zero).
Mediation Analyses
Because no evidence emerged for an association between the stress manipulation
and reward/loss learning, or between inflammatory responding and reward/loss learning,
no analyses were conducted to explore inflammatory responding as a mediator of stressinduced changes in reward/loss learning.
Exploratory Analyses: Lifetime Stress Exposure as a Moderator of Stress-Induced
Cytokine Activity
We applied bootstrapped LMMs to test the 3-way interaction of stress/control
condition by time by life stressor count for all cytokines. A significant 3-way interaction
in this case would suggest that the stress manipulation differentially impacted the time
course of cytokine responding depending on prior life stress exposure.
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Significant interaction terms emerged for the pro-inflammatory cytokines IL-1β
(β = -0.15, SE = 0.07, 95% CI: [-0.31, -0.03]), IL-6 (β = -0.21, SE = 0.10, 95% CI: [-0.41,
-0.01]), and IL-8 (β = -0.18, SE = 0.08, 95% CI: [-0.34, -0.02]). Results for proinflammatory cytokines are visualized in Figure 5. Notably, estimates of interaction terms
for pro-inflammatory cytokines were all negative, such that models predicted a steeper
increase in pro-inflammatory cytokines in the stress condition (relative to the control
condition) when individuals had experienced fewer life stressors. By contrast, the models
predicted more negative slopes for changes in pro-inflammatory cytokines in the stress
condition (relative to the control condition) when individuals endorsed more life
stressors.

118

Figure 5. Moderation of stress effects on the time course of pro-inflammatory cytokine
concentration. Graphs depict model estimates of marginal effects based on observed
parameter values.
Additionally, analyses revealed a significant interaction term for the antiinflammatory cytokine IL-4 (β = 0.22, SE = 0.08, 95% CI: [0.07, 0.41]), and these results
are visualized in Figure 6. The interaction term for this anti-inflammatory cytokine was
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negative. Thus, the model predicted more negative slopes for the change in antiinflammatory cytokines in the stress condition (versus more positive slopes in the control
condition) for individuals who endorsed fewer life stressors. For individuals who
endorsed more life stress, the model predicted flatter slopes in both conditions.

Figure 6. Moderation of stress effects on the time course of anti-inflammatory cytokine
concentration. Graph depicts model estimates of marginal effects based on observed
parameter values.
Exploratory Analyses: Lifetime Stress Exposure as a Possible Moderator of StressInduced Changes in Reward and Loss Learning
To test whether prior stress exposure might moderate a relation between the stress
manipulation and reward/loss learning, we applied bootstrapped LMMs.
For the Pessiglione task, we tested the 3-way interaction between stress/control
condition, trial type (reward vs. loss), and life stressor count, with percent optimal choice
as the outcome variable. The 95% bootstrap confidence interval contained zero.
Therefore, we accept the null hypothesis that the stress manipulation did not differentially
impact reward vs. loss learning in a different manner for those with high vs. low prior
stress exposure. In summary, analyses revealed no evidence that prior stress exposure
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moderated the impact of the stress manipulation on instrumental learning in the
Pessiglione task.
For the PRT, we examined the 3-way interaction between stress/control condition,
task block (1 vs. 2), and life stressor count. Response bias served as the outcome variable.
Again, the 95% bootstrap confidence interval contained zero, yielding no evidence that
the stress manipulation affected reward learning in the PRT differentially based on prior
stress exposure.
Follow-up Analyses: Associations between Self-reported Affect and Inflammatory
Changes
Because earlier analyses produced results that were unexpected given the existing
literature (e.g., failing to indicate an effect of stress on pro-inflammatory responding), we
conducted follow-up tests. Bootstrapping regressions revealed no association between
change in self-reported affect pre- to post-stressor with change in cytokine concentrations
from baseline to 40 min post-stressor or from baseline to following reward tasks, for any
cytokine (all 95% confidence intervals contained zero). These analyses provided no
evidence to suggest that the individuals who were most impacted by the stressor in terms
of self-reported affect also experienced greater changes in inflammatory responding.
Discussion
This study examined inflammatory responses to stress as a possible mediator of
the impact of stress on motivated behavior, thought to be an important component of
anhedonia (Pizzagalli, 2014; Treadway & Zald, 2011). However, our investigation
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uncovered no association between the experimental stressor and pro-inflammatory
responses, and furthermore, did not find an effect of stress on reward/loss learning.
Several explanations may account for these null findings. One possibility is that
the stressor applied here was not strong enough to induce changes in inflammatory
responding. However, the TSST has produced pro-inflammatory responding in numerous
other studies (Allen, Kennedy, Cryan, Dinan, & Clarke, 2014). Additionally, individuals
in the stress condition reported increased negative affect following the stressor, relative to
individuals who underwent control tasks, suggesting that the stressor was potent enough
to produce affective responding. Another possibility is that saliva provided an invalid
measure of inflammatory responding. Notably, saliva represents a noninvasive method of
assaying inflammatory markers that can be collected without training in venipuncture,
and a number of studies have reported an impact of stress on inflammatory markers in
saliva (see Szabo et al., 2020 for a review). However, one report suggested that the
correlation between markers in saliva and blood plasma is low for most cytokines
(Williamson, Munro, Pickler, Grap, & Elswick, 2012). These low correlations may raise
questions about the validity of markers in saliva. Finally, the concentrations of salivary
cytokines reported here are considerably lower than in some studies that have reported
significant effects of stress on salivary cytokines, even at baseline measurement. For
instance, Slavich and colleagues (2010) reported baseline log-transformed IL-6
concentrations between 1.2 and 1.4 log pg/mL on average, whereas the baseline mean in
the present study was -1.4 log pg/mL. Maintaining cytokine samples requires storage at
low temperatures (-80ºC), and problems with storage may have led to low cytokine
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concentrations. Any or all of these factors may have contributed to null findings in the
present study.
In addition, the present study found no evidence to support an effect of stress or
stress-induced inflammation on reward/loss learning. Notably, some prior studies that
reported an association between stress and reward sensitivity have used different stressors
than were applied here, such as threat of shock (Berghorst et al., 2013; Bogdan &
Pizzagalli, 2006). As a result, we cannot rule out the possibility that a different stressor
may have led to the expected differences in motivated behavior.. However, some other
prior studies have also failed to show an effect of stress on motivated behavior (Treadway
et al., 2017), and one study that applied the TSST found only an indirect effect through
inflammation, but no direct effect on behavior (Boyle et al., 2020). Thus, null findings in
the present study may be best understood in the context of mixed prior literature in
humans. Such inconsistent past findings may result from the absence of a true effect. On
the other hand, it is important to note that the stressors that participants undergo in human
studies tend to be mild and time-limited relative to those employed in nonhuman animal
studies, due to practical and ethical constraints (Stanton et al., 2019). Thus, mixed
findings could also reflect a weak or unstable effect, possibly due to necessary ethical
limitations of human-subjects research. Additional studies with greater statistical power
(e.g., larger sample sizes) could help to provide clarity, since such studies would have
greater statistical power to characterize a potentially small effect.
In light of concerns regarding the validity of inflammatory assessment in the
present study, our exploratory findings should be interpreted with caution. Our model
estimates suggested a decreased change slope for anti-inflammatory cytokines (IL-4 and
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IL-10) in the stress group (see Figure 4). However, these results are unexpected based on
the past literature, since meta-analyses of studies using both blood serum (Marsland et al.,
2017) and saliva (Szabo et al., 2020) suggest that an increase in IL-10 following stress
relative to controls would be expected. Furthermore, we found that for individuals who
endorsed more prior life stressors, the laboratory stressor was associated with a decreased
change slope for broadly pro-inflammatory cytokines, such as IL-6 (see Figure 5).
However, by contrast, past work suggests that more early stress exposure is associated
with an increased inflammatory response following subsequent stress exposure
(Fagundes & Way, 2014). Again, problems with measurement of cytokine concentration
in the present study may have contributed to these unexpected results.
Overall, results from this study do not support the hypothesis that inflammatory
responding mediates the relation between stress and anhedonia, but also cannot rule out
this possibility. This study was limited by several issues, some which are inherent to
experimentation with human subjects (i.e., ethical concerns that limit the severity and
chronicity of stressors that can be applied), and some of which may have resulted from
implementation difficulties (e.g., possible degradation of samples in storage leading to
low cytokine concentrations; small sample size). Future studies could mitigate these
limitations, e.g., by collecting larger sample sizes.
Laboratory studies in humans provide a relatively well-controlled method for
examining the effects of stress on biology and behavior. At the same time, such work is
necessarily limited in the types of stressors that can be studied. Supplementing
experimental work with longitudinal, observational studies in large samples could shed
additional light on how severe, real-world stressors relate to inflammatory signaling and
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anhedonic behavior/self-reported symptoms. These studies are difficult to undertake,
since they require repeated follow-ups and intensive life stress assessment, and involve
the deployment of considerable resources. Still, such work may provide key etiological
information that could inform therapeutic intervention and preventative care. Thus,
continued research on the pathways to anhedonia represents a crucial step in furthering
understanding of and treatment for this debilitating condition.
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Chapter 6: General Discussion and Future
Directions
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Synthesis and Conclusions
The present set of studies aimed to contribute to a clearer understanding of the
etiological pathway to stress-induced anhedonia. The first study (described in Chapter 3)
sought to determine whether certain types of stress are especially strongly associated with
anhedonia. The next two studies tested potential biological mediators of the link between
stress and anhedonia: frontostriatal connectivity (Chapter 4) and inflammatory activity
(Chapter 5).
Anhedonia was associated with number of stressors endorsed
Overall, our results are consistent with prior work (e.g., Keller et al., 2007)
suggesting a link between stress and anhedonia. Across two studies (see Chapters 3 and
4), a greater number of stressors endorsed was linked to more severe anhedonia. This
effect was detectable over a 6-month time window, using a detailed stress assessment
(Chapter 3) as well as over a 2-year time window, with a much larger sample size and
much more limited inquiry into potential life stressors (Chapter 4). Indeed, compared
with a more complex model designed to account for key dimensions of stress, such as
chronicity, severity, independence, and interpersonal focus, only number of stressors
endorsed appeared to provide a non-zero contribution to prediction of anhedonic
symptoms (Chapter 3). Taken at face value, these results might appear consistent with the
notion that “more stress leads to more severe anhedonia.”
However, several caveats apply. First, in both studies, assessment of both stress
exposure and anhedonic symptoms relied, at least to some extent, on self-report. Thus,
this association remains vulnerable to (some) biases that can occur in self-report data. For
instance, based on the present data, we cannot rule out the possibility that individuals
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who endorse more stressful life events also endorse more anhedonic symptoms due to a
tendency to report negative life circumstances in general, absent any causal link. Notably,
individuals with MDD exhibit a bias towards recall of negatively-valenced material
(Matt, Vázquez, & Campbell, 1992), although this bias may be specific to sad material
rather than threat stimuli (Gotlib et al., 2004). At the same, both studies (Chapters 3 and
4) inquired about specific events rather than relying on free recall, which may mitigate
risk of recall bias, although it cannot be entirely ruled out. Additionally and crucially, the
LEDS (see Chapter 3) uses diagnosis-blind rating panels to assign stressor severity
ratings instead of relying on participants’ judgment of stressor severity. Thus,
participants’ stress responses (including emotional reactions) do not factor into the
assessment of stress exposure. Nevertheless, overall, our results are consistent with
findings that negative life events are associated with MDD onset (Kendler et al., 1999)
and linked to anhedonia (Keller et al., 2007).
Of note, the estimated effects of number of stressors endorsed were relatively
small across studies. In our study of stressor characteristics predicting anhedonic
symptoms (Chapter 3), the median posterior estimate of the effect of number of stressors
endorsed was 0.48 (SD of anhedonia scores = 19.18), suggesting a very small predicted
increase in anhedonic symptoms for each stressor endorsed. In our study using UK
Biobank data (Chapter 4), the effect of number of stressors endorsed was similarly small
(B = 0.06 across the discovery and replication samples, where anhedonia was measured
on a 0-3 scale).
No evidence of a link between acute, mild stress and reward sensitivity
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Although we identified an association between stress and self-reported anhedonia,
our work did not detect an effect of stress on reward sensitivity, either on its own or in
relation to loss sensitivity (Chapter 5). Links between MDD and diminished reward
sensitivity (Pizzagalli et al., 2008) and decreased allocation of effort towards accruing
rewards (Treadway, Bossaller, Shelton, & Zald, 2012) have been previously documented
and are thought to contribute to anhedonia (Pizzagalli, 2014; Treadway & Zald, 2011).
Additionally, prior laboratory studies using threat of shock as a stressor have reported an
effect of decreased reward sensitivity (Berghorst et al., 2013; Bogdan & Pizzagalli,
2006). By contrast, in our own work, several possibilities could explain the failure to find
a relation between stress and sensitivity to rewards. For example, we applied a socialevaluative stressor rather than using threat of shock. Thus, differences from the stressors
used in prior work may have contributed to null findings, possibly due to insufficient
stressor severity or duration.
On the other hand, our findings may be limited by the behavioral tasks chosen to
assess anhedonic-like changes in behavior following stress. That is, assuming that stress
alters neurobiological/behavioral processes that contribute to anhedonia, the tasks we
chose may be insensitive to these alterations, at least under circumstances of mild stress.
To facilitate comparison with existing work, our experimental study (Chapter 5) made
use of established tasks with associations with MDD (Pizzagalli et al., 2008) and vaccineinduced inflammation (Harrison et al., 2016). However, as others have noted, anhedonia
may represent a multifaceted and potentially heterogeneous construct (Treadway & Zald,
2011). Future research could incorporate measures that take a different approach to
characterizing reward processing deficits that may be associated with stress and
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anhedonia (see further discussion in Unresolved Questions and Future Directions,
below).
No support for frontostriatal connectivity or inflammatory responding as a mechanism
for stress-induced anhedonia
We also found no support for two potential biological mechanisms of stressinduced anhedonia: altered frontostriatal functioning (Chapter 4) and inflammatory
responding (Chapter 5). However, we are unable to rule out these mechanisms due to
limitations of the studies included here. In our study of frontostriatal connectivity as a
potential mediator of the stress-anhedonia link, we were limited by minimal assessment
of both anhedonia, which was measured using a single self-report item, and life stress,
which was based on yes/no responses to only six potential stressors over a broad 2-year
time window. Additionally, our study of the impact of stress-induced inflammation on
anhedonic behavior was limited by questionable validity of inflammatory assessment.
Concentrations of inflammatory cytokines were considerably lower than in past work,
raising the possibility that samples degraded during the storage and analysis process.
Additional work could clarify whether frontostriatal function and inflammatory
responding are indeed plausible mediators (see below).
Unresolved Questions and Future Directions
Perhaps regrettably, the studies included here raise more questions than they
answer. More research is needed, both to address the methodological limitations of this
dissertation and also to expand the study of stress-induced psychopathology in general.
The sections below discuss unanswered questions and suggest ideas for future work.
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Is “number of stressors endorsed” a proxy for chronicity or severity of stress exposure?
As noted above, we found that number of stressors endorsed was associated with
self-reported anhedonia (Chapters 3 and 4). However, it remains unclear whether this
finding reflects the impact of multiple kinds of stressors, or may instead be a proxy for
effects of stressor chronicity or severity. Indeed, one explanation that could account for
this finding is that more chronic (i.e., more frequent) exposure to stress leads to greater
anhedonic symptoms. However, using stress interview data (Chapter 3), analyses did not
yield a credible non-zero effect of single stressors that are chronic in nature (e.g.,
financial stress lasting at least 4 weeks). Still, evidence from other work suggests that the
definition of chronic stressors could plausibly influence the strength of the effect. Indeed,
a study that used a higher length cutoff (1 year) to define chronic stressors found that they
were more strongly associated with depressive symptoms than acute events (McGonagle
& Kessler, 1990), whereas studies that have used a lower cutoff (4 weeks) have found
that acute events are more robustly associated with depression severity (Muscatell et al.,
2009) or no difference (Rojo-Moreno et al., 2002). One way to address this seeming
discrepancy using the LEDS data from Chapter 3 would be to limit the data to only
individuals who endorsed chronic stressors, and test whether stressor length is related to
anhedonia scores. Such an analysis is feasible with the datasets used in this dissertation,
and we plan to pursue this possibility as a future direction.
Another possibility is that multiple concurrent stressors create a more severe
experience of stress. Yet analyses revealed no evidence of an effect of stress severity
(Chapter 3). Notably, we included only events above a certain severity threshold in our
analyses, and stressors must necessarily meet a certain threshold of severity to be
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included in a life stress assessment. Accordingly, perhaps stressors above a certain level
of severity contribute in a comparable fashion to anhedonic symptoms. However, an
alternate explanation is that once an individual has developed substantial anhedonic
symptoms, additional stressors exert a diminished impact on anhedonia. Thus, severity
may have an impact, but only for individuals with milder symptoms. One way to test this
possibility would be to examine diagnostic status as a moderator of the impact of stress
severity on anhedonia. If a “ceiling effect” is present, we would expect stress severity to
be associated with anhedonic symptoms in individuals without MDD, but not individuals
who are already experiencing MDD. Additionally, for individuals with MDD, we might
expect that stress exposure in the 6 months prior to MDD onset (as opposed to 6 months
prior to assessment) exerts the strongest effect on anhedonic symptoms. However, this
hypothesis rests on the assumption that that anhedonic symptoms remain constant
throughout a depressive episode, which is the reason such analyses were omitted from the
present dissertation. Even so, this hypothesis merits follow-up work.
Are there other, important dimensions of stress that were omitted here?
In our study using the UK Biobank sample (Chapter 4), financial difficulties
(discovery B = 0.22 and replication B = 0.25) appeared to predict anhedonia scores more
strongly than number of stressors endorsed (B = 0.06 across the discovery and replication
samples). This result raises the question of whether some stressors do have a larger
impact than others, even though our work may have failed to identify the key factors that
categorize less impactful vs. more impactful stressors. For instance, using the dimensions
of stress that have historically predicted MDD onset (such as independence and
interpersonal focus), we found no effects on anhedonia (Chapter 3). Thus, we cannot rule
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out the hypothesis that some stressors may be more influential than others, and we may
have simply failed to test the dimensions of stress that most efficiently parse stressors
with respect to their impact on anhedonia. Notably, the LEDS stress interview categorizes
stressors according to 10 categories that were not included in the model, such as
education, occupation, housing, and finances. We plan to test whether these domains
contribute to anhedonic symptoms in future research efforts.
Why did we fail to find support for frontostriatal connectivity and inflammation as
mediators of stress-induced anhedonia?
While our work failed to find support for altered frontostriatal functioning or
inflammatory responding as mediators of the relation between stress and anhedonia, we
may have failed to detect an effect due to study limitations. With respect to our
investigation of frontostriatal connectivity (Chapter 4), the UK Biobank sample included
only minimal assessment of life stress and anhedonia. In this sense, our study suffered
from a common trade-off in large-scale research: Because the time and resources
necessary for a particular assessment scale with sample size, and because such efforts
often have broad aims, these projects frequently opt for many, briefer assessments rather
than few but thorough measures. However, progress in etiological research will require
large samples that provide both adequate statistical power and also thorough, detailed
stress measurements. Since stress exposure is relevant to virtually all psychopathology,
large-scale projects that include relatively detailed stress measurements could be vital to
elucidating the etiology of multiple forms of mental illness. Such an undertaking could
make use of judicious methodological compromises. For instance, the STRAIN (Slavich
& Epel, 2010; Slavich & Shields, 2018) is a self-report instrument that inquires about a
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large number of stressors and also assesses the frequency, timing, and duration of each
stressor. This measure omits some of the features of gold-standard stress assessment. For
example, it relies on participants’ personal judgment to capture the severity of stressors,
in contrast to the LEDS, which uses standardized anchors and blind rating panels
(Harkness & Monroe, 2016). However, the STRAIN is considerably briefer than the
LEDS (~30 minutes to complete as opposed to potentially several hours), and still
assesses more stressors and provides more temporal detail than several widely-used stress
checklists (e.g., Brugha & Cragg, 1990; T. H. Holmes & Rahe, 1967). A large study that
included a measure like the STRAIN, alongside well-validated clinical inventories and
biological measures of broad interest (such as resting-state functional connectivity or
inflammatory markers), could provide a useful resource for advancing the study of
psychopathology in general. However, such large-scale efforts would require a
substantial mobilization of resources, likely coordinated across multiple sites and
research teams.
In the meantime, smaller studies of stress-induced inflammation and motivated
behavior could focus on different behavioral assessments. In our work, we relied on tasks
that have been previously associated with MDD and vaccine-induced inflammation.
However, future work could make use of tasks that probe other facets of motivated
decision-making, such as habitual vs. “cognitive” or model-based reinforcement learning.
Indeed, basic research on stress and decision-making suggests that stress may shift
learning towards more habitual strategies (Otto, Raio, Chiang, Phelps, & Daw, 2013;
Schwabe et al., 2007; Wirz, Bogdanov, & Schwabe, 2018). Notably, it remains unclear
whether such conceptualizations of reinforcement learning offer a generative framework
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for elucidating the etiology of anhedonia. However, basic research on the effects of stress
on decision-making may offer compelling candidate mechanisms that could then be
tested in clinical populations.
Finally, we may have failed to uncover evidence for mediation of stress-induced
anhedonia by frontostriatal connectivity or inflammatory responding because no true
effects exist. Stress-induced anhedonia may instead be mediated through a different
pathway, such as through altered activity in energy homeostasis systems (see Chapter 2).
For instance, GLP-1 neurons are thought to at least partially mediate hypophagic
responses to stress (Maniscalco et al., 2015). Yet GLP-1 activity also appears to diminish
motivation for other rewards, such as alcohol and drug rewards (Hayes & Schmidt,
2016), possibly via projections to NAc and VTA (Alhadeff et al., 2012). Thus, GLP-1
activity (and/or other energy homeostasis mechanisms) could mediate the link between
stress-anhedonia. However, these pathways have received little attention in the anhedonia
literature. In part, the lack of research may be due to difficulties with studying energy
homeostatic pathways in humans. As an example, GLP-1 neurons originate largely in the
brainstem (Merchenthaler et al., 1999), and brainstem imaging requires special
considerations, such as the use of ultrahigh-field MRI scanners (Sclocco, Beissner,
Bianciardi, Polimeni, & Napadow, 2018). Nevertheless, exploring additional candidate
mechanisms for stress-induced anhedonia may yield important insights for the diagnosis
and treatment of this condition.
Concluding Remarks
At present, widely-used diagnostic systems for psychiatric disorders rely on
descriptive classifications rooted in clinical consensus (Clark et al., 2017). To make
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much-needed advances in diagnosis, treatment, and prevention, it will be crucial to
develop empirically-supported etiological theories for psychiatric problems such as
anhedonia. This dissertation attempted to elucidate a causal pathway to anhedonia by
examining the impact of particular types of stress and putative mechanisms through
which stress might influence anhedonia. We were unable to find support for the
mechanisms in question, or to effectively classify stressors that are especially associated
with anhedonia. However, we propose that additional work is merited to examine how
complex adaptations that unfold in response to stress could give rise to hedonic and
motivational changes. We acknowledge that the pathway toward greater etiological
knowledge will be lined with discarded hypotheses and null results, but hope that future
work will lead to a revolution in care for those individuals whose lives are impacted by
debilitating anhedonia.
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Appendices A and B
Appendix A (Detailed Model Diagrams for “Key Dimensions of Stress and
Contributions to Anhedonia”) and Appendix B (Model Diagnostics for “Key Dimensions
of Stress and Contributions to Anhedonia”) are available online:
https://yale.box.com/s/01x7dbeuk2a0f2wrby57zpeugzp5dmjo
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